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Abstract
Improving Characterization of Small Molecules Metabolites using Enhanced
Molecular Reaction and Ionization Techniques
Sandra Nyemudzai Majuta

Metabolomics is an emerging “omics” field, which is comprised of the study of small
molecule metabolites in biological systems. It can be argued that the abundances of metabolites
within biological samples, such as tissue and plasma, are indicative of various physiological
states. Thus, metabolomics analysis has the potential in the clinical scientific field to be an
effective tool for early disease diagnosis as well as for proposing and monitoring new treatments
for diseases. However, full characterization of the metabolome complement is often hampered by
the wide diversity of metabolites, which also exhibit an extremely large concentration range in
biological samples. Added to these challenges is the presence of numerous isomeric and isobaric
species thereby presenting difficulties for analytical platforms.
Hybrid techniques such as liquid chromatography (LC) and gas chromatography (GC),
combined with mass spectrometry (MS) have been widely used in complex mixture analysis
associated with metabolomics investigations. For example, LC-MS ‘omics methods have been
broadly utilized to investigate conditions such as cardiovascular disease, cancer, diabetes and
neurodegenerative disorders. Despite progress in techniques for metabolome characterization,
the major challenge of accurate compound identification remains and stems primarily from an
inability to distinguish isomeric and isobaric species by MS as well as to identify the lowabundance species within metabolomics mixtures.
The research presented here focused on developing novel techniques combined with
mass spectrometry to significantly enhance the ability to accurately identify challenging
metabolites. In one embodiment, rapid, solution-phase hydrogen deuterium exchange (HDX)

coupled with MS was demonstrated as a means for distinguishing small-molecule metabolites.
Additionally, in this work, a new approach for predicting the solution-phase hydrogen/deuterium
exchange (HDX) reactivity for new compounds (e.g., newly emerging drugs) using hydrogen-type
parameterization was demonstrated. In another study, experiments attempted to address the
extremely challenging structural diversity of carbohydrate compounds including isomeric species.
The power of using a combination of orthogonal analytical measurements for distinguishing
monosaccharide stereoisomers as well as disaccharide linkage isomers by employing rapid (μs
timescale) solution-phase HDX with MS detection.
In one noteworthy project, field-enabled cVSSI has been combined with high-flow, liquidchromatography (LC)-MS to establish the current ionization advantages for metabolomics
investigations. This work was directed towards developing capabilities for identifying lowerabundance species that may be masked by signals from higher-abundance species in a complex
mixture. In the final installment of this work, a combination of techniques, ion mobility
spectrometry-mass spectrometry (IMS-MS), and gas-phase HDX using D2O vapor were used as
tools to distinguish and establish unique isotopic distribution patterns for disaccharide ion species.
Molecular dynamics (MD) simulations were applied to in-silico structures for HDX accessibility
modeling. The results suggest that different charge assignments for different ions may be in part
responsible for the different HDX levels observed. The work described in these four projects, is
discussed with an eye toward future efforts to enable the wide-scale adoption of these methods
in metabolomics workflows.
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1. Introduction: Characterization of Metabolites, Enhanced Molecular Reactions
and Ionization Techniques
1.1. Metabolomics
‘Omics is a collection of various disciplines in biology such as genomics, lipidomic,
proteomics, and metabolomics [1]. The aim of ‘omics investigations is to completely characterize
and/or quantify the respective molecules namely, nucleic acids, lipids, proteins and metabolites
that ultimately translate into biomolecular structure and function within living organisms. At its
simplest form, metabolomics is the study of the metabolic processes and metabolites within
biological systems [2]. Metabolites are small molecules that can give information about specific
cell functions or biological processes [3]. The metabolome is unique, dynamic and intimately tied
to organism phenotype [2]. During the development and progression of a disease, molecules –
including metabolites – termed biomarkers can vary significantly. Thus the physiological steadystate conditions of cells and their dynamic metabolic response to environmental stimuli are
reflected in metabolomics analysis [4, 5]. As a result, metabolomics analysis has the potential to
be an effective tool for the performance of early disease diagnosis through the identification and/or
quantification of a validated biomarker(s) [6,7]. Because of this potential, the field of metabolomics
has expanded rapidly spurred in part by parallel improvements in bioanalytical platforms and
methods for data analysis [5].
Comparative metabolomics is a field of study where scientists seek to correlate the
physiological state of an organism with the relative abundances of metabolites determined by
comparing the metabolite complements of different organism populations [8, 9]. The potential for
comparative metabolomics analyses to aid in the study of disease has been applied to a wide
range of human conditions including cardiovascular disease, cancer, and neurodegenerative
disorders [10–14]. Therefore, it can be argued that the main goal of metabolomics investigations
1

is to identify new markers for early disease diagnosis and monitoring disease progression [10,
15]. Biomarker discovery also plays a significant role in the elucidation of mechanisms of disease
development, which may result in earlier disease diagnosis and in proposing new treatments for
diseases [1, 7, 10].Therefore, developing new methods of analysis which generate increased
accuracy (and thus confidence) in comparative analyses is a significant goal.
Compared to proteomics or genomics, comparative metabolomics studies presents the
greatest challenge in characterization and quantification analyses to analytical chemists because
constituent compounds are the most diverse group varying greatly in size, chemical makeup, and
concentration (and thus functionality) [16–18]. Overall, there are tens of thousands of widely
diverse compounds which challenges the different analytical measurement techniques to
distinguish and identify such species based on differences in innate physicochemical properties
as well as to accurately quantify such species from complex mixtures [1]. Metabolites differ in
molecular structure, functional groups, molecular weight as well as the presence of numerous
isomers and isobaric species within complex mixtures [1]. Of these characteristics, one of the
greatest challenges in metabolomics analysis is the characterization of large numbers of isomeric
and isobaric compounds by mass spectrometry [15]. Also, there is a large dynamic range of these
compound and this presents challenges when attempting to observe low-abundance species in
the presence of chemical noise from coexisting higher-abundance species [1, 4]. Processes that
allow for data acquisition for thousands of biological samples and the comparison of the
concentrations of the various metabolites in those samples requires highly robust and
reproducible analytical techniques. Overall, these salient features of the metabolome present
obstacles to high-throughput comparative studies and invite the development of new technologies
for metabolomics analysis [5].

2

1.2. Methods used for Metabolomics Analysis
Both nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS)
based comparative metabolomics have been applied successfully to numerous in vitro and in vivo
studies [1, 16, 19]. These studies have revealed metabolic pathway disruption in many disease
types including cardiovascular disease [20, 21], diabetes [22, 23], inborn errors of metabolism
[24, 25], alcohol-induced liver injury [26], and various cancers [22]. Although metabolomics can
successfully identify metabolic signatures and mechanisms of disease, there are some challenges
that need to be considered when implementing a metabolomics study [1].
Mass Spectrometry (MS) has been widely used in complex mixture analysis and it
provides valuable information about the molecular weight and abundance of different compounds
[27]. To address the complexity of the samples, traditional separation methods including both
condensed- and gas-phase chromatography have been coupled with MS. Therefore,
instrumentation methods such as liquid chromatography-mass spectrometry (LC-MS) [28, 29],
gas chromatography-mass spectrometry (GC-MS) [30] and ion mobility spectrometry-mass
spectrometry (IMS-MS) [31, 32], have been frequently employed for this purpose. Many methods
employed for metabolomics analyses suffer limitations in that they require long analysis times,
the use of isotopically labeled standards, and identification is often limited to those compounds
contained within the searchable database. In addition, there are limitations in the separation of
isomeric and isobaric species and as such, there is an especial need to develop an approach that
helps distinguish isomeric species on a rapid timescale. Furthermore, the improvement in
technologies is necessary to enable more comprehensive metabolome-wide analyses to reveal
subtle biopathways that are associated with phenotype and phenotype change.
Despite the promise of obtaining new diagnostic and prognostic biomarkers, the field of
comparative metabolomics has often not delivered reliable molecular candidates. Indeed, the lack
of progress has resulted in the suggestion that a paradigm shift is required with regard to the
3

techniques/methods employed in comparative metabolomics analyses for biomarker discovery.
Evidence of this lack of progress in comparative metabolomics analyses comes from the National
Institutes of Health (NIH), which has issued a recent center grant solicitation for the development
of metabolomics technologies [33]. In the solicitation, the NIH pinpointed a key problem in
comparative metabolomics analyses as the inability to obtain high-confidence compound
identification with current analytical strategies. In this proof-of-principle work, methods with novel
techniques that can be used in high-throughput analyses to dramatically improve the numbers of
high-accuracy compound assignments are presented. Particularly the power of using the
measurement of separate and distinct physicochemical properties (orthogonal measurements) to
aid identification are presented.
For complex mixture analysis, the key to improving component identification is that such
properties be distinctive, and this leads to the concept of using orthogonal measurements. The
orthogonality of such measurements (and thus the resolving power) is increased if the
physicochemical properties are not correlated [34]. For ‘omics analyses, this has translated into
the usage of hybrid techniques such as LC coupled with MS. With a LC-MS approach, the first
measurement is often related to the polarity of a compound and the latter measurement
determines the mass. As indicated above, traditional measurement strategies are falling short in
their ability to identify compounds in very complex mixtures such as those encountered in
comparative metabolomics due to their limited resolution.
In the work presented here, novel analytical strategies have been developed identifying
compounds and distinguishing isomers using an enhanced ionization technique termed capillary
Vibrating Sharp-edge Spray Ionization (cVSSI) developed by Professor Peng Li and his research
group at West Virginia University [35, 36]. Additionally, HDX (solution-phase and gas-phase) is
used as an enhanced molecular reaction technique. Finally, solution-phase and gas-phase
separation techniques, LC and IMS, respectively, are also used in the separation of components
4

in complex mixtures. These methods provide distinctive pieces of information for measured
metabolites that can significantly aid compound identification. Thus, the work has the potential to
transform high-throughput comparative metabolomics analyses because of the relatively high
degree of orthogonality among measurements, their robust nature, and their simplicity for
adaptation into ‘omics workflows. One especially innovative aspect of the work presented here
is the amenability of the methods for identifying compounds that have not been analyzed
previously. That is, two approaches are ideally suited for developing strategies for predicting the
measurements of unknown analytes such as newly emerging drugs and/or their metabolites.
Additionally this work has the potential to expand the utility of database identification approaches
by expanding identifying signatures to be used for compound identification as well as signature
prediction capabilities.

1.3. Nano Electrospray Ionization (nano-ESI)
Electrospray ionization (ESI) is a soft ionization technique [37] that has been shown to
transfer intact biomolecular ions, as well as solution phase non-covalent complexes into the gas
phase. Related to the work presented here, ESI has been widely used for the analysis of
oligosaccharides [38]. The advent of nanoelectrospray ionization (nESI) has considerably
extended the usability of ESI in the analytical mass spectrometric laboratory [38, 39]. One of the
remarkable features of nESI is its extremely low sample consumption. Here, only a few microliters
of analyte solution are sufficient for molecular weight determination and structural investigations
by mass spectrometry. nESI is more than just a minimized-flow ESI; the low solvent flow rate also
enhances the mechanism of ion formation. As a consequence, the area of ESI-MS applications
is significantly increased. For example oligosaccharides, glycosides as well as glycoproteins can
be analyzed more easily than with normal ESI [38, 40]. The same holds for the analysis of noncovalent complexes sprayed directly from aqueous solutions.
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As an extension of nESI capabilities, theta-capillaries have been used by Derrick and
Williams for monitoring reactions with MS [41]. This method is accomplished by loading into each
channel a different analyte and then expelling each [39] by applying the same polarity of spray
voltage to each channel. It has been shown that for experiments in which reactions take place
through the fusion of micro droplets, the rates are up to a million times faster than in the bulk
solution [42–44]. With regard to enhanced reaction rates, the use of theta capillaries has been
considered to be an extension of desorption electrospray ionization(DESI) techniques [45]. One
major difference is the absence of the sheath gas in the nESI setup with theta-capillaries and the
presence of a much smaller tip size. These differences offer advantages in that, produced droplets
are much smaller and slower, effectively changing the mixing dynamics of colliding droplets [46].

1.4. Capillary Vibrating Sharp-Edge Spray Ionization (cVSSI)
The technique of VSSI [36] briefly introduced above, utilizes mechanical vibration of a
substrate containing a sharp edge to induce nebulization of liquid samples without the use of high
voltage. A VSSI device is fabricated by attaching a piezoelectric transducer to a microscope
glass slide using epoxy glue [36]. By placing a droplet at the edge of the glass slide and applying
RF voltage to the transducer, liquid samples are aerosolized in which a droplet plum is produced
right at the sharp edge of the glass slide due to mechanical vibration. The device is usually placed
between 0.5 to 1 cm from the inlet of the mass spectrometer to achieve ion production and
detection. With the new ionization source, successful ionization of various chemical species in
both positive and negative ion mode and spanning a broad range of molecular classes (small
molecules, peptides, proteins, carbohydrates, and nucleic acids) was demonstrated [36]. Voltagefree VSSI is advantageous in terms of its simplicity and flexibility, relatively low cost, and ability
to enable in situ analysis through direct, contact‐based nebulization that is not possible with other
voltage‐free methods.
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One disadvantage with VSSI is that, in its original form it is not suitable for direct coupling
with LC or other continuous flow-based MS analyses. This has led to the development of capillary
Vibrating Sharp-edge Spray Ionization (cVSSI) which is an extension of the previous VSSI method
described above [35, 47, 48]. cVSSI is achieved by attaching a short piece of fused-silica capillary
on top of the vibrating glass slide employed by VSSI. Here the nebulization of the liquid sample
occurs directly at the outlet of the capillary as a result of mechanical vibration without using a
high-speed nebulization gas or a high electrical field. As with VSSI, for cVSSI, ESI-like mass
spectra have been obtained for many small molecules, peptides, and proteins [48]. In this work,
we will demonstrate the utility of cVSSI for metabolite identification. Additionally, cVSSI has been
shown to be compatible with LC-MS analysis. This platform has also been demonstrated as fieldenabled cVSSI for microflow LC-MS to enhance metabolomics analysis (Chapter 4). In this
approach, a voltage is applied to the emitter-tip capillary of the cVSSI device [48].

Figure 1-1. Schematic of the cVSSI-MS experimental setup with a bias voltage. Adapted with
permission form reference [48].
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It is important to study biomolecules in their “native” solution conditions, the aqueous media,
because these conditions generally stabilize biomolecular structure [49]. ESI with 100% aqueous
solutions often requires the use of high voltages to generate the highly-charged droplets, [50] This
is particularly problematic for negative ion mode analyses often leading to corona discharge that
degrades the analyte ion signal as well as the ESI tip [49]. Thus, native MS under negative ion
mode conditions is greatly affected by corona discharge and often results in unstable signal and
low signal-to-noise (S/N) ratios [39]. Although there exist several workarounds for addressing the
corona discharge issue, the most widely used involves the use of a heated nebulization gas [51,
52]. Dr Li’s research group has demonstrated that a combination of the cVSSI process and the
application of a negative bias voltage (Figure 1-1) can effectively suppress corona discharge for
aqueous solutions in negative ion mode analyses [48]. The ion signals for various analytes
including oligosaccharides, proteins, peptides and DNA have been shown to improve significantly.
This method shows an enhancement in ion intensity of ~10 to 100 fold and an ~3 to10-fold
enhancement in S/N compared to commercial ESI sources equipped with a nebulization gas
system. In the work presented here, the cVSSI setup (Figure1-1) has been modified (see Chapter
Three) to develop a method for distinguishing carbohydrates isomers.

1.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
LC-MS is an analytical technique that separates molecules including, proteins, nucleic
acids, or small molecules in complex mixtures prior to mass analysis [53]. Here molecule
separation occurs on the surface of a column’s stationary phase through a portioning process
(into and out of the liquid mobile phase and stationary phase).Compounds eluting from the
column are then electrosprayed and the ions are detected by the mass spectrometer. Technology
development in LC-MS instrumentation for comparative proteomics and metabolomics
experiments occurred for nearly 2 decades yet researchers still struggle with mixture complexity.
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A major limitation lies in the analytical signals which are often masked by co-eluting higher-signal
ions providing a hindrance to the detection and quantitation of low-signal species [28, 29]. To
improve the analytical signals in ‘omics analyses, researchers have utilized nanoflow LC
separations. With low flow rates, the overall ionization efficiencies by nESI are improved. The
limitations to this technique are that, it also greatly diminishes the sample throughput and the
analytical signal is less stable with regard to constant ion production [54].
More recently, researchers are beginning to advance the use of microflow LC separations
due to the issues of stability and throughput associated with the nanoflow regime [54–56].
However most of the microflow LC separations still require the use of a heated nebulizer gas for
improved sensitivity. Various voltage-free ionization sources such as solvent-assisted inlet
ionization (SAII) [57] and thermospray have been utilized with LC-MS [58]. These ionization
methods do present limiting in their flexibility for using LC as a useful orthogonal technique for
metabolite identification.

This results from the relatively low ionization efficiency for these

techniques as well as the potential to rapidly foul the ESI source and inlet optics of the mass
spectrometer. In the work presented here, field-enabled cVSSI was coupled with microflow LC
separations. This has resulted in unparalleled ionization efficiency (compared to the state-of-theart source) which can be used with the most robust, high-throughput separation strategy. The
work presented here has the potential to provide the unmet needs of ultrasensitive LC-MS
analysis for high-throughput studies; this can have an indelible impact on the investigation of
diseases such as cancer, diabetes, and cardiovascular disease.

1.6. Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS)
IMS is a gas-phase separation technique in which gaseous ions are distinguished based
on their shape and size as they travel in a pressurized drift tube under the influence of a constant
electric field [59, 60]. Drift tube ion mobility instruments consist of an ionization source, an ion
trapping device, an electrodynamic ion gate to generate the pulse of ions, a linear drift tube
9

containing a neutral buffer gas, and an ion detector (mass analyzer in many cases) [60] . For the
work presented here, ions are generated in the nESI source and are then directed into the drift
tube which is pressurized with He buffer gas. The drift tube consists of stacked cylindrical lenses
separated by an electrically non-conductive material [60]. A potential gradient is applied to the
lenses along the drift tube axis to produce a uniform electric field [60, 61]. The drift field is applied
to essentially transfer the pulse of ions through the drift tube and eventually into the mass
analyzer. Overall, the ions are separated based on their mobilities which are directly proportional
to the drift velocities of the ions.
IMS-MS provides a two-dimensional dataset of m/z versus tD values where tD is the time
that it takes for the ions to traverse the drift tube. tD can be translated to orientationally-averaged
collision cross section (CCS) values. Experimental CCS (Ω) values can be calculated using the
following expression:

Ω=

1
(18𝜋) ⁄2
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𝑃
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In Equation 1, L is the length of the drift tube, P is the pressure of the buffer gas, and N is the
number density of the buffer gas at STP. ze is the charge of the ion, E is the electric field strength,
T is the temperature of the buffer gas, kB is Boltzmann’s constant, and mI and mb are the masses
of the ion and the buffer gas, respectively. Theoretical CCS values can also be calculated for
computer-generated ion structures. Often, the in-silico structures are generated using molecular
dynamics (MD) simulations. The xyz coordinates together with the molecular masses of atoms
and partial charges obtained from the structure files (psf) can then be used to calculate CCS
values using the Mobcal software suite [62, 63]. CCS values are a specific physicochemical
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property of the molecular ions. IMS measurements are very reproducible and so CCS values can
be used as an additional tool for the characterization of compounds in complex mixture analysis
[64]. Because IMS separates components in complex mixtures based on ion structure and charge,
ions of small CCS exit the drift cell at earlier tD values compared with larger ions that encounter
more collisions with the He buffer gas [64, 65]. Because of the capability to rapidly obtain
compound specific information in the form of the ion CCS, IMS is finding increased utility in ‘omics
analyses [59]. Additionally, IMS-MS offers several advantages in sensitivity because it increases
the overall measurement peak capacity and enables the separation of isomeric and isobaric
species of metabolites as demonstrated in previous work [66, 67].

1.7. Hydrogen/Deuterium Exchange (HDX)
Early in the 1950s, it was observed that when a protein is exposed to D2O, labile hydrogen
atoms connected to the amide backbone would exchange with deuterium. Hydrogen/deuterium
exchange (HDX) is a molecular reaction in which labile hydrogen atoms are replaced by a
deuterium atom when exposed to deuterated solvents resulting in a neutron mass gain. The
heteroatom-bonded hydrogens have pronounced acidic properties compared to carbon-bonded
hydrogens and thus can easily be replaced [68]. The use of HDX allows the determination of the
composition and structures (conformers) of molecules. In addition, it also allows of investigations
chemical and biochemical pathways. In protein studies, the rates of exchange for the hydrogens
depends on the accessibility of the amide bond to the solvent and the dynamics of the protein
structure [69]. Side-chain exchangeable hydrogens in residues such as Asn (-CONH2), Asp (COOH), Ser (-0H), Cys (-SH), or Lys (-NH2) have been shown to exchanges at much faster rates
than backbone amide hydrogens. Protein HDX behavior is useful information in the study of
protein conformations and structural dynamics [70].
There are a number of widely established methods that involve HDX combined with
nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry [71, 72]. NMR-HDX
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based strategies require that highly-purified proteins and metabolites be soluble at high
concentrations. This is a limitation in the pharmaceutical industry because this often eliminates
the possibility of determining structural features of drugs and metabolites that are in the discovery
stage of drug development which are only available in limited quantities. That said, HDX is one
of the most popular techniques in MS to be used for biomolecular structural elucidation because
of its sensitivity and selectivity. The technique has been widely implemented for both solution [73–
75] and gas -phase studies [15, 76–79].

1.7.1. Solution-phase HDX
Solution-phase HDX is based on an acid or base catalyzed mechanisms proposed by
Englander and coworkers [80]. The exchangeable hydrogens of proteins include the backbone
NH group and the side-chain protons bound to N, O and S atoms. Carbon-bound hydrogens do
not exchange readily. The underlying proton-transfer steps depend on the acid-donating and
base-accepting propensities of the acceptor and donor groups. Although polar-group hydrogens
are labile, they are covalently bound and exchange with solvent hydrogens only because of
distinctive chemical reactions. Exchangeable protons such as those in hydroxyl or amine groups
exchange protons with the solvent in a protic solution and, if D2O is the solvent, deuterons will be
incorporated at these positions. Exchange rates depend on the pKa of the exchange site, the pH
and temperature of the solution [63, 81], the hydrogen isotopes involved [82], the
presence/absence and makeup of buffer salts[80], and the presence of any added solvents [82].
Since this exchange is an equilibrium reaction, the molar amount of deuterium must be high
compared to the exchangeable protons of the substrate. For instance, deuterium is added to a
protein in H2O by diluting the H2O solution with D2O (e.g. 10-fold). Usually exchange is performed
at physiological pH (7.0 to 8.0) where proteins are in their native ensemble of conformational
states [80].
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Based on the considerations described above for rapid solution-phase HDX, it should be
possible to “freeze” out differing amounts of incorporated deuterium based on different exchange
rates provided sufficiently fast reaction quenching is achieved. Under such conditions, different
metabolites may exhibit unique HDX behavior and this would impose some compound selectivity
in the form of unique isotopic distributions (signature) that could be used to confirm compound
identity. For proteins and peptides, during solution-phase HDX, labile protons on the side chains
and backbone amide sites which are not protected from solution generally exchange rapidly [80].
For the latter hydrogen type, exchanges occur on the order of a few to a few tens per second [80].
It has been shown that for small peptides, the solvent can access all labile hydrogens and readily
exchange hydrogens for deuteriums [83]. HDX for biomolecules in solution has been employed
to understand biophysical processes, with a recent emphasis on kinetics [83]. In a separate
application, deuterium-exchange for metabolomics analyses has been combined with LC-MS
methods [84–86] but such analyses are often limited as they require large amounts of deuterated
solvent. Additionally the approach decreases throughput as separate LC runs are required to
obtain mass spectra of the unreacted parent ions.

1.7.2. Gas-phase HDX
Gas-phase HDX-MS was introduced nearly two decades ago and has been used since
that time for the structural analysis of proteins and peptides [77, 83, 87–93]. Gas-phase HDX-MS
has been applied to the study of diverse biomolecules such as proteins, peptides, carbohydrates,
and nucleotides [88, 94–98]. In gas-phase HDX, several structural parameters affect HDX rates.
The relative proton affinities of the solvent and the gas-phase ions as well as the availability of
the sites to surface collisions with the reagent gas play crucial roles in HDX [79]. Beauchamp and
coworkers suggested that lower basicity reagents, such as D2O and CH3OD, proceed via a “relay”
mechanism [93] for reactions with protonated peptides, while the higher basicity ND3 reagent
gives rise to an “onium” mechanism [79]. In the relay mechanism for protonated species, a proton
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is shuttled from the site of protonation in a hydrogen-bonded complex onto D2O in concert with
the transfer of a deuteron from D2O to a distant, less basic site on the analyte ion as shown in
Figure 1-3. Therefore, overall, the propensity for deuterium incorporation should be a function of
the proximity between the charge site and the exchange sites [83].

Figure 1-2. The Relay mechanism for the HDX reaction between D2O and a hypothetical protein. Adapted
with permission from reference [83]. Formation of the hydrogen-bonded complex facilitates the transfer of
the proton from the charge site to the D2O molecule and a deuterium to an oxygen atom on the amide group
having a lower gas-phase basicity.

Gas-phase HDX techniques have been successfully used to distinguish isomeric
carbohydrate ions by Uppal et al. [76]. In separate HDX-MS work, Robinson studied exchange
levels for 5‘- and 3‘-nucleotide monophosphates and the 3‘,5‘-cyclic nucleotides in negative ion
mode using ESI-FTICR MS [96]. Helming et al. [99] used ND3 as the nebulizer or curtain gas
and showed the feasibility of HDX for structure elucidation of ESI-formed ions. This method
demonstration was limited on two fronts. First it was limited to infusion of a highly purified sample
into a mass spectrometer, and second, its usefulness for obtaining tandem mass spectrometry
information was not demonstrated [99].
More recently gas-phase HDX coupled with IMS-MS measurements is shown to hold
significant potential for the study of conformational forms of biomolecular ions and has been
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evaluated as a method for mixture characterization [15, 92, 100].

For the latter studies, the

different HDX levels have been proposed to break the tD and m/z correlation to some degree
thereby providing increased peak capacity. Indeed, experiments presented here show that
compound ions exhibit unique HDX reactivities that can be used to distinguish separate molecular
isomers [15].

1.8. Molecular Dynamics (MD) Simulations
Gas-phase HDX kinetics modeling combined with molecular dynamics (MD) simulations
has been previously utilized to present an ability to assign structures to gas-phase ion conformers
[15, 77, 92].The hydrogen accessibility scoring (HAS) approach employs an in-house script that
has been developed in Professor Valentine’s lab [62]. The model is based on the “relay”
mechanism for HDX as presented by Beauchamp and coworkers and Chan and Enke [101, 102].
HAS relies on experimental HDX data as well as numerous computer generated ion structure
candidates to predict HDX patterns [62]. Two factors are considered in the HAS model: 1) surface
accessibility as more exposed (accessible to collisions) labile hydrogens are expected to
exchange more rapidly than buried heteroatom hydrogens, and 2) exchange hydrogen
accessibility to charge sites and original incorporation sites. Therefore, surface hydrogens that
are close to charge sites and incorporation sites were scaled to have higher HAS values. Using
this approach, the HDX contribution from each site for each ion conformer was determined and
the overall exchange was computed for each ion conformer revealing proposed, favored ion
structures. The ability to increase the accuracy of ion structure assignments represents an
important step toward developing HDX-MD simulation tools for predicting gas-phase HDX
behavior. This ability could have implications for the assignment of compounds that are not
observed in metabolite databases such as newly emerging drugs and their metabolites.
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In the work presented below, extensive MD simulations are applied to in-silico structures
to better understand the HDX behavior of isomeric carbohydrate ions. Here, hydrogen
accessibility modelling is used to relate the experimental data to the structures of disaccharide
ions. The distances between the various charge sites and the labile hydrogens were used to better
understand the charge site configurations for disaccharide ions. The work shows that MD
simulations may be used to help interpret IMS-HDX-MS datasets and may indeed be used in the
future to predict the behavior of carbohydrate ions [63, 103–108]. Notably some structural
information of biomolecules can also be obtained by simply comparing MD simulations with the
CCS values alone [63, 109, 110].
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2. Rapid Solution-Phase Hydrogen/deuterium Exchange for Metabolite Compound
Identification
Reprinted with permission from Journal of The American Society for Mass Spectrometry: Rapid
Solution-Phase Hydrogen/Deuterium Exchange for Metabolite Compound Identification. Sandra N. Majuta,
Chong Li, Kinkini Jayasundara, Ahmad Kiani Karanji, Kushani Attanayake, Nandhini Ranganathan, Peng
Li, Stephen J. Valentine C. J. Am. Soc. Mass Spectrom. (2019) 30:1102-1114

2.1. Introduction
Metabolomics is an increasingly important field of scientific research, finding application
in diverse areas of study including clinical, agricultural, and forensic investigations [1–4]. It is
argued that the abundances of metabolites within biological samples, such as tissue and plasma,
are indicative of various physio- logical states [5–9]. This concept thus led to the field of
comparative metabolomics where research seeks to correlate organism physiological state with
the relative abundances of metabolites determined by comparing the metabolite complements of
different organism populations [10]. A main goal of metabolomics investigations is to identify new
molecular markers for early disease diagnosis and for monitoring disease progression [12–18].
Metabolome characterization for comparative studies is often hampered by the fact that
there is a wide diversity of metabolites presenting challenges in data acquisition and data
interpretation to be used in quantification of compounds of such complex mixtures [4, 19, 20]. For
example, metabolites differ in molecular structure, the types and numbers of functional groups,
and molecular mass [12, 21]. This imparts various physiochemical characteristics, which are often
exploited to aid mixture characterization. This also results in the presence of numerous isomers
and isobaric species [12, 19], rendering the identification of such species by analytical platforms
that use mass spectrometry (MS) particularly challenging [22, 23]. Additionally, molecular concentration ranges in biofluids correlating to specific physiological states can span more than an
order of magnitude [19, 24]. Such a large dynamic range of these compounds particularly present
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challenges when attempting to observe low-abundance species in the presence of higherabundance species [25]. These factors present obstacles to high-throughput comparative studies
and invite the development of new technologies for complex mixture analysis [12].
A number of analytical strategies, including liquid chromatography-mass spectrometry
(LC-MS) [26–29], gas chromatography-mass spectrometry (GC-MS) [2, 30–33], and nuclear
magnetic resonance (NMR) spectroscopy [34–37], have been employed to conduct comparative
metabolomics experiments. Studies of this nature have revealed metabolic pathway disruption in
many disease phenotypes, including cardiovascular disease [10, 36, 38], diabetes [39, 40], inborn
errors of metabolism [41, 42], alcohol-induced liver injury [43, 44], and various cancers [13, 30,
45, 46]. Despite such progress, the major challenge of compound identification remains [19].
Indeed, such a need recently prompted a request for application (RFA) by the National Institutes
of Health (NIH) focused on enhancing the ability to accurately identify metabolite molecules in
complex mixtures [47].
In the development of new strategies employing supplemental measurements for
compound identification, the concept of informing power should be given careful consideration
[15, 48, 49]. That is, the added measurement is most useful if it provides information about
compound physicochemical properties that are not covered by the other measurements. An
example of the power of this approach for metabolomics is in the usage of chemical labeling to
identify and quantify metabolites and to elucidate metabolic pathways [18, 50–55]. Related to
compound identification discussed here, some researchers have proposed coupling the gasphase separation technique known as ion mobility spectrometry (IMS) with MS [56–62] and LCMS [63–65] to aid compound identification. The combination is highly functional due to the relative
measurement times of the approach and because the drift time of an ion is associated with its
shape-to-charge ratio as opposed to mass-to- charge (m/z) [66]. Despite the power of the
combination, it has been noted that ion drift times and m/z values are correlated and therefore
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the resolving power (and thus informing power) of the combined approach has some limitations.
Recognizing these limitations, recently, it was proposed that gas-phase hydrogen deuterium
exchange (HDX) combined with IMS-MS could disrupt the correlation to some degree and provide
ion information that is proposed to lead to higher accuracy assignments [67–69]. Such information
is extremely reproducible and is obtained at no cost to the experimental timescale. Recently, the
power of a gas-phase HDX approach was demonstrated in the distinguishing of oligosaccharide
isomers [70].
With the same goal of increasing the informing power of measurements, more than a
decade ago, it was proposed that solution HDX could be used to provide compound specific
information in the form of the number of acidic hydrogens [71]. Liu et al. [67] and Ohashi et al.
[68] used deuterium oxide as the LC mobile phase to enable online HDX exchange experiments
to facilitate drug metabolite identification. This technique is limited to some degree in that the
preparation of all the samples is performed in D2O and requires the use of all deuterated buffer
for the mobile phases. Ramanathan et al. have recently demonstrated that the use of LC-MS
equipped with an ESI source and D2O as the sheath liquid allows HDX exchange experiments to
be performed online [71]. The shift in average m/z of the ions from the deuterated molecule
allowed the number of exchangeable protons to be determined for individual compounds. These
could then be associated with the number of acidic hydrogens and thus aid identification efforts.
For such an approach, a problem could arise in that some species may not be expected to
undergo complete exchange, thereby not permitting a determination of the total number of acidic
hydrogens.
For solution-phase HDX, a question arises as to whether or not a better (or
complementary) method would be a database searching approach where, for experiments
conducted under prescribed conditions, the resulting isotopic distributions could be used for
compound matching. Also, relatedly, strategies could be developed to allow for the prediction of
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isotopic distributions for species not present in a compound databases similar to approaches
attempting to predict the mobilities of specific ions [14, 72–74].The work reported here utilizes
solution-phase HDX with MS to address these questions. The technique employs the use of a
dual capillary setup where solvent mixing occurs at the tip in a manner similar to that
demonstrated with the use of theta capillaries for monitoring reactions with MS [75–78]. Zare et
al. have demonstrated a method for rapid solution hydrogen-deuterium exchange in liquid droplets
in which nano-ESI was employed with a theta capillary and MS analysis [79]. With a goal to
continue developing functionality for a new, voltage-free ionization source for metabolomic
analyses, here, capillary vibrating sharp-edge spray ionization (cVSSI) was employed to perform
rapid HDX measurements [80, 81]. Molecule-specific isotopic distributions are demonstrated with
the approach, and a preliminary method for isotope distribution prediction is presented.

2.2. Experimental
2.2.1. Chemicals and Solvents
Metabolite standards and solvents were purchased from several commercial entities. The
following analytes were obtained from Sigma-Aldrich (St. Louis, MO, USA): aniline (ACS reagent
≥ 99.5%); glycine, L-glutamine, and L-glutamic acid (Reagent Plus® ≥ 99%HPLC);L-lysine(≥ 98%
TLC); L- asparagine (≥ 98% HPLC); acetaminophen (Sigma Ultra mini- mum99%); 3-amino-1propanol and adenine, (reagent grade ≥ 99%); dopamine hydrochloride, L-homoserine,
butylamine, L- arginine, L-lysine, L-serine, pyrrolidine, piperidine, and pyrrole (reagent grade
98%); and glacial acetic acid, deuterium oxide (99.9%). Guanosine, guanine, and pyrrole (99%)
were purchased from Acros Organics (New Jersey, NJ, USA). L- Alanine and L-serine (99%) were
purchased from Alfa Aesar (Haverhill, MA, USA). L-Tyrosine (98%) was obtained from AK
Scientific Inc. (Union City, CA, USA), and tryptophan was obtained from MP Biomedicals LLC.
(Santa Ana, CA, USA) L-Hydroxyproline, acetic acid, methanol, water, and ammonium acetate
(Optima® LC/MS) were purchased from Fisher Chemical (New Jersey, NJ, USA). All standards
28

were used without further purification. Table 2-1 in the Supporting Information provides the
structures of the compound to be examined in this study.

Table 2-1. Names and structures of the metabolite standards
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a Monoisotopic

mass of each compound
structure drawn using the chem drawer software suite
c Average deuterium uptake from triplicate measurements. Values were obtained from m/zweighted isotopic distributions before and after HDX.
d% deuterium uptake computed by dividing the deuterium uptake value by the total number of
exchangeable hydrogens.
eNumber of exchangeable hydrogens. The types of hydrogens considered are shown in brackets.
Ar, Am, and Guan stand for aromatic, amide, and guanidino, respectively.
*Triplicate measurements provided the same value.
fT-test P value
b Molecular

30

2.2.2. Sample Preparation
Single standard solutions of concentration 0.01 mg/ml in a 100-mM ammonium acetate
buffer solution were prepared. The ammonium acetate buffer was reduced to a pH of 4.75 (near
maximal buffering capacity) [82] by the addition of acetic acid. Butylamine was used as an internal
standard, and an appropriate amount was added to each solution to produce a final concentration
of 0.01 mg/ml.

2.2.3. Capillary Vibrating Sharp-edge Spray Ionization (cVSSI)
A detailed description of cVSSI has been described elsewhere [80, 81]. Briefly, the cVSSI
device was fabricated by attaching a piezoelectric transducer (7BB-27-4 L0, Murata diameter =
27 mm)) to one end of a no.1 microscope glass slide (w × l = 25 × 60 mm) (VWR, Radnor, PA,
USA) using epoxy glue. Two fused-silica capillaries, 5 cm in length each (360 μm o.d. × 100 μm
i.d.) were attached at a 60-angle counter clock- wise to the cover slide as shown in Figure 2-1 in
the Supporting Information. Two syringes (BD 1 ml) were connected to two thin wall tubing, which
were attached to a precision needle (BD 0.3 mm× 13 mm). The thin-wall tubing was connected
to the joined fused-silica capillaries. The two solutions were pumped using a Chemyx Fusion 4000
multi-channel syringe pump (Chemyx, Stafford, TX, USA), which is configured with two
independently controlled precision syringe pump channels with programmable step-rate
functionality. The syringe pump has a dual drive system allowing two independent pumping
channels to be controlled for simultaneous infusion and withdrawal at different flow rates. This
allows both syringes—one with D2O and the other with the analyte—to be controlled at different
flow rates. The reagent and analyte solutions were infused at rates of 10 and 4 μL min−1,
respectively. This produces rapid mixing of solution just prior to droplets emerging from the two
tips before they are introduced into the mass spectrometer inlet capillary. The RF signal applied
to the piezoelectric device was generated using a Tektronix function generator (AFG-1062,
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Tektronix, Beaverton, OR, USA) connected with an amplifier (Krohn-Hite 7500, Brockton, MA
USA), and the device is operated at ~ 95 kHz.

Figure 2-1. a) Schematic representation of the cVSSI device.

Shown are the microscope slide,

piezoelectric transducer, the dual capillary emitters, the mixed droplet plume and the MS inlet. The cVSSI
device was made by attaching a piezoelectric transducer (7BB‐27‐4 L0, Murata diameter = 27 mm)) to one
end of a No.1 microscope glass slide (w×l = 25×60 mm) (VWR) using epoxy glue. Two fused-silica
capillaries, 10 cm in length each (360 μm OD × 100 μm ID) were attached at a 60° angle counterclockwise
to the microscope glass slide. b) Photograph of the cVSSI dual capillary emitter with the generated plume.
c) Photograph of the piezoelectric transducer attached to the cover slide for size comparison.
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2.2.4. Mass Spectrometer
A Q-Exactive hybrid Quadruple-Orbitrap mass spectrometer (Thermo Fisher, San Jose,
CA) was utilized for all MS measurements. The instrument features high-performance quadrupole
precursor ion selection with high-resolution, accurate- mass (HR/AM) Orbitrap detection. Mass
spectrometric analysis was achieved by placing the cVSSI device Figure 2-1 in the Supporting
Information) 0.5–1 cm from the inlet of the mass spectrometer. The resolving power was set to
70,000 for all full MS scans. All experiments were conducted in positive ion mode using a m/z
scan range of 50–500 (1 microscans). The AGC target was set to 5 × 105, and the inlet capillary
temperature was maintained at 250 °C. Samples were analyzed in random order with ion
chronograms being collected for ~ 3 min. Measurements were performed in triplicate to examine
HDX variability.

2.2.5. Experimental Deuterium Uptake
The amount of deuterium incorporated is determined based on the shift in average m/z
values between the compound before and after the addition of D2O at the tip of the dual capillary
device. This was calculated using the weighted isotopic distributions of the unreacted and HDX
product ions using an in- house script. The deuterium incorporated was then scaled by rationing
the deuterium incorporation level of the internal standard of butylamine to the average level
exhibited by butylamine across all samples. Treating all exchangeable hydrogens equally, the
faction exchanged was then obtained by dividing the scaled deuterium incorporated value for
each compound by the total number of exchangeable hydrogens in the same compound. This
average exchange level for each hydrogen is used in later comparisons with moiety-dependent
exchange parameters (see below). Average-scaled deuterium incorporation values and the
fraction exchanged are provided in Table 2-1.
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Table 2-2. Intrinsic HDX parameters for different hydrogen types

aNames

of the hydrogen type
representations of the hydrogen types drawn using the chem drawer software suite
c HDX parameters calculated using nonnegative linear regression with the MATLAB software suite. Errors
represent one standard deviation about the mean.
b Structural
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2.2.6. Moiety-Dependent HDX Parameters
To compute moiety dependent HDX parameters for each measurement of a single
compound, an equation is set up of the form shown in Eq. (1)
𝑛1 𝑃1 + 𝑛2 𝑃2 … = 𝑦

(1)

In Eq. (1), n1 and n2 correspond with the number of ex-changeable hydrogens in moiety 1 and
moiety 2 (e.g., hydroxyl, primary amine, and carboxylic acid), respectively. P1 and P2 represent
the HDX parameter for the respective hydrogen types. This parameter is intended to reflective
the referenced moiety contribution to the overall exchange level (y in Eq. (1)). The various
hydrogen types are indicated numerically in Table 2-2.
Using the data for all the compounds measured, a system of equations can be set up of
the form shown in Eq. (2).

∑𝑛𝑗=1 𝑛𝑖𝑗 𝑃𝑗 = 𝑦𝑖

(2)

In Eq. (2), j ranges from 1 to n (total number of HDX parameters; see Table 2-2), and i ranges
from 1 to m (total number of HDX measurements; see Table 2-1). This system of equations can
be solved for the individual parameters and their associated error using matrix manipulations
similar to that described previously [73, 83]. The theoretical deuterium uptake for each compound
can be computed using the derived parameters and the appropriate form of Eq. (1). Unpaired ttest were performed (https://www.graphpad.com/quickcalcs/ttest1/?format=SD) to determine the
significance of the differences in the prediction accuracies of the predicted uptake values using
the moiety parameters vs parameterizing all hydrogens equally.

2.2.7. Hypothetical Isotopic Distributions
Using the average fractional hydrogen uptake values or the moiety dependent HDX
parameters, it is possible to construct hypothetical isotopic distributions for various ions. This is
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accomplished using in house script employing a pseudo-Monte Carlo approach [12]. Here, for
each hydrogen type, the exchange propensity comparator is computed for each of 10,000 ions
using a random number selection process. This value is then compared with the probability of
exchange, which is either the average fractional exchange or the HDX parameter. If the
comparator value is ≤ to the average fractional exchange or the HDX parameter, the hydrogen is
considered to have exchanged on the selected ion. Then, the total number of hydrogens that have
exchanged for each ion is obtained by summing up the hypothetical exchanges for each hydrogen
type. Relative isotopic intensities are then represented as a histogram of this hypothetical data.

2.3. Results and Discussions
2.3.1. Selection of cVSSI for HDX Experiments
To detect moiety-specific differences in HDX efficiencies re- quires a method for
extinguishing the reaction after a very short timescale [84–86]. Zare and coworkers used a theta
capillary in which nano-ESI was employed to perform rapid HDX experiments [79]. This seminal
work demonstrated that a hydrogen- dependent rate could be determined for those hydrogens
occupying a primary amine on phenylethylamine. Overall, it was possible to determine the rate of
the consecutive D1 and D2 exchanges using the isotopic distributions produced as a function of
needle distance to the MS inlet orifice. These studies inspired the central idea presented here—
rapid HDX and MS analysis can be used to distinguish compounds having different function- al
isomers. For the work presented here, a new ionization approach—cVSSI—was selected to
produce the ions of the various compounds. A major motivation for this selection is the desire to
develop a voltage-free method for compound ionization with an ultimate goal of improving in-situ
metabolomics analyses. Although this work does not present in situ analysis, it continues a series
of efforts to build the foundation for such a platform by presenting additional functionality related
to metabolomics analyses.
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Briefly, cVSSI can produce micrometer-sized droplets from a solution infused through a
fused-silica capillary. This is accomplished by vibrating a substrate (microscope slide in this case)
to which the capillary is attached (Figure 2-1). Because the droplets are generated in a field-free
region (i.e., without the aid of an applied voltage), they can require a significantly longer time to
reach the MS inlet com- pared with ESI. Indeed, measuring the distance the droplets travel in a
measured amount of time using an oil-covered glass surface provides an estimate of droplet
velocity of ~ 0.1 m/s. Therefore, HDX reaction times of tens of milliseconds are expected. This is
sufficient time to result in significant HDX. (Figure 2-2) shows the typical isotopic distributions
obtained for butylamine after undergoing HDX in cVSSI droplets. Here, the D1 isotopologue is
the dominant feature, and significant contributions from the D2 and D3 ions are observed.
To use an approach that matches the HDX isotopic distributions for compound
identification requires that such distributions can be generated with high reproducibility. In
proposing the use of gas-phase HDX for isotopic distribution matching, this reproducibility has
been demonstrated [12]. For the solution-phase experiments reported here, this would require
that similar mixing is achieved at the capillary tips and that similar droplet lifetimes are achieved
among the separate experiments. To achieve similar conditions, a waiting period of ~ 2 min was
employed to ensure that the proper flow rates were established by the syringe pump between the
experiments for the different samples. Additionally, care was taken to place the cVSSI device in
the same position ensuring a similar distance to the MS inlet. Figure 2-2 shows the reproducibility
in isotopic distribution that is achieved after butylamine undergoes HDX. Overall, for this homeassembled device, relatively high reproducibility is achieved. That said, at times, the D2
isotopologue could become as large as the D1 peak possibly suggesting different mixing
efficiencies. Therefore, to mitigate against such a problem, butylamine was used as an internal
standard to obtain scaled deuterium uptake values (see “Experimental” section above).
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Figure 2-2. Isotopic distributions of the [M+H]+ ions of butyl amine, the internal standard, for twocomponent mixtures containing (a) L-homoserine, (b) tryptophan and (c) asparagine.

Spectra were

obtained after the compounds were exposed to D 2O flow (see manuscript for details). Deuterium
incorporation for the standard was typically ~1.35 corresponding with 45.0% exchange. The use of the
internal standard ensured correct calibration for the limited times that inefficient mixing occurred and
improved the overall reproducibility of the deuterium uptake values represented in Table 2-1.
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2.3.2. Compound-Specific HDX Behavior
To examine whether or not compound-specific HDX behavior is observed from the cVSSI
experiments, it is instructive to compare the isotopic distributions of species not only having
different functional groups but also displaying similar mass. Figure 2-3a, b shows the HDX isotopic
distributions for butylamine and 3- amino propanol ions, respectively. The m/z shifts suggest
deuterium incorporation levels of 1.35 and 1.49 for the respective analytes. Because butylamine
and 3-amino propanol have 3 and 4 exchangeable hydrogens (including the added proton), the
fraction exchanged is 0.45 and 0.37, respectively. Therefore, it would appear that the cVSSI
approach is sufficient to capture differences in HDX behavior that are related to compound makeup. This is also evident for dopamine and acetaminophen as shown in Figure 2-3c, d, respectively.
Here, the fractions incorporated are observed to be 0.42 and 0.29 for the respective analytes.
With the analyses shown in Figure 2-3, a question that arises is the degree to which
different types of hydrogens contribute to the observed differences in fraction exchanged. To
consider this, a comparison is made between the HDX behavior of arginine and tyrosine. This
comparison provides the opportunity to see the effect of a large number of similar hydrogens.
Overall, arginine and tyrosine have 8 and 5 exchangeable hydrogens. Both amino acids contain
primary amine and carboxylic acid hydrogens. Tyrosine contains an additional indole hydrogen
that is available for exchange. The majority (~ 63%) of exchangeable hydrogens for arginine
reside on the sidechain guanidino group. Therefore, a comparison of fraction exchanged for these
two amino acids, to some degree, reveals the efficiency of the exchange on the guanidino group.
From the isotopic distributions for these amino acid residues in Figure 2-3, deuterium uptake
levels of 2.22 and 1.82 are calculated for arginine and tyrosine, respectively. This corresponds
with respective exchange fractions of 0.28 and 0.36, and, assuming that carboxylic acid
hydrogens on both amino acids exchange at similar rates and that the same holds true for the
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primary amine hydrogens on both amino acids, the difference can be attributed to comparatively
inefficient exchange by the guanidino hydrogens.

Figure 2-3. Experimental isotopic distributions for the [M+H] + ions of butylamine (a), 3-amino-1-propanol
(b), dopamine (c), acetaminophen (d), arginine (e), and tryptophan (f) after solution exposure to D2O (see
text for details). The minimum and maximum isotopologues peak is labeled in each of the spectra.

2.3.3. Isotopic Distribution Matching for Compound Identification
To consider whether the current approach could be used for isotopic distribution matching,
it is instructive to compare the HDX data for two molecules that have nearly identical molecular
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weight and the same number of exchangeable hydrogens. The molecules glycine and 3-amino
propanol have average molecular weights of 75.07 and 75.11 g mol−1, respectively. Each ion has
4 exchangeable hydrogens. Figure 2-4a, b shows the HDX spectra obtained for glycine and 3amino propanol, respectively. There are notable differences in the isotopic distributions. For
glycine, the D2 isotopologue is the most intense peak, and the D1 is only slightly smaller.
Additionally, the D3 isotopologue is of greater intensity than the D0 peak. For 3-amino propanol,
these relative intensities are re- versed. That is, the D1 is larger than the D2 peak and the D0 is
larger than the D3 feature. These isotopic distributions correspond to deuterium uptake levels of
1.70 and 1.46 for the glycine and 3-amino propanol ions, respectively.

Figure 2-4. Experimental isotopic distributions for the [M+H]+ ions of glycine (a) and 3-amino-1-propanol
(b) after solution exposure of the compounds to D2O (see text for details). Panels (c) and (d) show
hypothetical distributions for glycine and 3-amino-1-propanol obtained by treating all hydrogens as having
equal probability for exchange. The minimum and maximum isotopologue peak is labeled in each of the
spectra.
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Although the relative peak intensities of the mass spectra in Figure 2-4a, b shows clear
differences, such differences are distinguishable only if the overall approach is very reproducible.
As indicated above and demonstrated in Figure 2-2, the approach appears to be highly
reproducible. Indeed, from triplicate measurements the uncorrected, average uptake values are
1.68 ± 0.07and 1.47 ± 0.02 deuterium for glycine and 3-amino propanol, respectively. Although
these values indicate a statistically significant difference in deuterium uptake, it is instructive to
consider how the “worst-case scenario” (respective HDX levels of 1.61 and 1.49) is revealed at
the isotopic distribution level. Hypothetical isotopic distributions under this scenario have been
created as described in the “Experimental” section. Here, 40.25 and 37.25% of the hydrogens
were allowed to exchange within populations of glycine and 3-amino propanol ions, respectively.
The resulting isotopic distributions are shown in Figure 2-4c, d. Although the distributions in Figure
2-4c, d show the respective shifts in m/z,the relative ordering of peak intensities is the same for
the experimental results indicating that even under the “worst-case scenario,” at least the most
significant isotopologues would retain their relative order with respect to intensity.

2.3.4. Moiety-Specific HDX Parameters
A significant challenge with any database search approach for compound identification is
whether or not the compound of interest exists in the database. For example, to populate an HDX
database with results for all compounds in the Human Metabolome Data- base [24, 87] would
require a Herculean effort. Additionally, such a database would not contain emerging compounds,
such as new drugs or environmental compounds and their metabolites. Therefore, an approach
that would also allow for the prediction of deuterium uptake levels could provide an advantage in
compound identification. One way to accomplish this is to use a regression technique
demonstrated to predict ion mobilities for peptides based on their amino acid makeup [73]. In
comparison to the former studies, the numbers of the different hydrogens in the small molecule
42

replace the numbers of the different amino acid residues in the peptides. To accomplish the
regression, Eq. (2) can be written in matrix form as Ax = y, where A is a matrix containing
maximum numbers of rows and columns corresponding to the number of separate chemical
measurements and the number of different HDX parameters. Each row in this matrix is populated
by the number of different hydro- gens for each organic moiety. y is a vector containing all of the
measured deuterium uptake values for the separate measurements. The vector x, containing the
moiety specific HDX parameters, is obtained using the nonnegative linear regression function in
the MATLAB software suite (Matrix Science). A preliminary analysis has been performed using
nine different hydrogen “types “as indicated in Table 2-2. Table 2-1 also shows the values
obtained for the different HDX parameters and their associated error.
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Figure 2-5. Percent error for the predicted deuterium uptake for each of the compounds in the study. Blue
and orange symbols correspond to values obtained using the HDX parameters and the equal probability
exchange approach, respectively (see text for details). Compound names and structures as well as t-test
values are provided in Table 2-1.
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With the parameters, it is possible to predict (or retrodict) the expected deuterium uptake
levels by the various compounds. This is accomplished by multiplying the numbers of a given
hydrogen type by the corresponding parameter and summing these values for all hydrogen types
contained within a com- pound. For example, for serine, the hypothetical uptake would be
computed as the sum of the contributing hydrogens for primary amine, hydroxyl, and carboxylic
acid functional groups. Using the parameters provided in Table 2-2, the value obtained for serine
is 1.85 (3 × 0.36 + 1 × 0.36 + 1 × 0.41). This is in good agreement (~ 2.6%) with the average
experimental value of1.90. For comparison, it is also possible to retrodict deuterium uptake by
treating all hydrogens as equally efficient with regard to exchange (see above). If the total
deuterium uptake is summed for all measurements and divided by the total number of exchangeable hydrogens in all measurements, the fractional ex- change is 0.36 ± 0.04. For serine,
then the prediction becomes 1.80 (0.36 × 5) deuteriums. This is also in relatively good agreement
(~ 5.2%) with the experimental value but less accurate than the HDX parameters
The serine comparison would suggest that the HDX parameters might not necessarily
present a significantly better method for prediction of deuterium uptake levels. However, the HDX
parameters for primary amine, hydroxyl, and carboxylic acid hydrogens are all very similar in
value. Additionally, the values are like the fractional value computed for all hydrogens when they
are treated equally. Therefore, for some of the compounds, it might be expected that no (or
limited) advantage would be obtained from the HDX parameters. Figure 2-5 shows the relative
prediction power of the HDX parameters versus the average deuterium uptake prediction. Overall,
the exchange parameters outperform the average factional uptake for 14 of the 18 compounds.
Additionally, for 9 of these 14 cases, the improvement was observed to be > 2.5-fold with one
being as high as a factor of18. Conversely, in the cases where the equal hydrogen treatment
outperforms the exchange parameter approach, the values are relatively close. Across all
compounds used in this study, the average percent differences in deuterium uptake (theoretical
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versus experimental) are 4.6 ± 3.5 and 10.1 ± 7.1% for the exchange parameter and equal
hydrogen analyses, respectively. An online-unpaired t test calculator was used to compare the
means of the two groups (see experimental section). Table 2-1 shows the two-tailed P values that
were obtained. For the 18 compounds, 5, 3, and 2 exhibit P-values of 0 to 0.05, >0.05 to 0.10,
and >0.10 to 0.15, respectively.

2.3.5. Isotopic Distribution Prediction
It is instructive to consider whether or not isotopic distributions can be estimated to a
reasonable degree of accuracy using the HDX parameters. This is accomplished as described
above where the exchange probability of each hydrogen is simulated for 10,000 ions. This
analysis can be performed using either the HDX parameters or the equal hydrogens treatment for
comparison. Figure 2-6 shows this comparison for alanine and dopamine ions. Consider the
comparison for alanine where the percent error for predicted deuterium uptake was determined
to be 2.4 and 6.0% (Figure 2-6) for the HDX parameter approach and the equal hydrogen
treatment, respectively. Figure 2-6a shows the isotopic distribution that is estimated using the
HDX parameters for the probabilities of exchange for each hydrogen. In summary, there is
relatively good agreement in peak intensities for the D1 and D2 isotopologues and slightly less
agreement for the D0, D3, and D4 features. The agreement between the D2, D3, and D4
isotopologues is less for the equal hydrogen treatment, while the agreement for the D0
isotopologue improves slightly. From a visual inspection, it may be difficult to ascertain the degree
of difference between theoretical and experimental distributions. One value to compare is the
root-mean-square- deviation (RMSD) of the percent error for the isotopologue intensities
according to Eq. (3).

𝑅𝑀𝑆𝐷 =

2
|𝐼𝑇𝑖 −𝐼𝐸𝑖 |
)
𝐼𝑇𝑖

√∑(

𝑥 100

(3)

𝑛
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In Eq. (3), ITi and IEi are the intensities of the theoretical and experimental peaks for the ith
isotopologue, and n is the total number of isotopologues compared. For triplicate analyses of
alanine ions such as that shown in Figure 2-6a, b, and the RMSD values are 16 ± 1 and 29 ± 2%
for the HDX parameter approach and the equal hydrogen treatment method, respectively.

Figure 2-6. Experimental (dark blue traces) and theoretical (orange traces) isotopic distributions for [M+H] +
ions after solution exposure to D2O. Panels (a) and (b) show the comparisons for the HDX parameterization
method and the equal exchange probability method, respectively for alanine. Panels (c) and (d) show the
same comparisons for dopamine ions. The theoretical distributions are offset by 0.15 to 0.20 m/z units for
visual comparison purposes. The minimum and maximum isotopologues are labeled in each spectrum.

It is instructive to consider the difference in predicted isotopic distributions for a compound
for which a more significant difference in predicted deuterium uptake is achieved. For dopamine
ions, the percent errors in deuterium uptake prediction for the HDX parameter approach and the
equal hydrogen treatment are 2.9 and 15.6%, respectively. Figure 2-6c, d shows the isotopic
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distribution predictions using the respective ex- change probabilities. Briefly, for the D0, D1, and
D2 isotopologues, there is relatively good agreement (Figure 2-6c) for the HDX parameters
approach. For this same method, there is less agreement for the D3, D4, and D5 isotopologues.
Using the equal hydrogen treatment, the agreement between theory and experiment is worse for
all isotopologues with the exception of the base peak (D2 isotopologue). For dopamine, the RMSD
value for the HDX parameters (80.8 ± 5%) is relatively higher than that observed for alanine. This
results from the decreased agreement of the higher isotopologues as especially observed for the
D5 feature. That said, for dopamine ions, the RMSD value for the equal hydrogens treatment is
still significantly worse (128.0 ± 8%).

2.3.6. Physical Significance of the HDX Parameters
The HDX parameters present a significant challenge in associating a physical significance
to their relative values. A first examination shows a relative ranking in exchange probability as
phenol > carboxylic acid > secondary amine, primary alcohol, primary amine, analine > amide,
guanidino, and indole. From this ranking, it is clear that the exchange probability cannot be
associated with compound pKa. For example, the pKa values for phenol, primary alcohol, and
guanidino groups are ~ 10, ~ 16, and ~ 13.6, respectively. The pKa for carboxylic acids is typically
~ 5. Therefore, no correlation can be drawn between the HDX propensities as estimated by the
parameters and pKa. That said, it is long established that HDX of different peptide groups is
dependent on a number of factors including solution temperature and pH as well as ionic strength
[84]. A separate comparison can be made between the HDX parameters and the relative rates of
exchange for different peptide groups. For example, decreased rates have been reported before
for guanidino, amide, and indole peptide groups [88, 89]. Conversely, higher exchange rates are
reported for primary amine, hydroxyl, and carboxylic acid peptide groups. Thus, there is qualitative
agreement between the HDX parameters and rate constants reported elsewhere.
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Although this preliminary study provides some agreement with data provided by NMR
experiments, any improvement in agreement to other experiments or utility of usage for compound
identification requires consideration of several factors. One factor that should be investigated
more thoroughly is the usage of a greater number of compounds to provide even more
assessments for determining probabilities of exchange for different hydrogen types. Related to
this is that, with a greater number of compounds, more parameters can be used to de- scribe the
HDX process of the different analytes. For example, in this work, all guanidino hydrogens are
treated equally, even though NMR has suggested slight differences in exchange rates of ε-and ηhydrogens [88]. Thus, with a greater number of compounds, it may be possible to divide the
parameterization of some hydrogens even further according to subtle differences in local chemical
environment. Such work may significantly improve the predictions of deuterium uptake and
isotopic distributions.
As a final consideration for method improvement, we consider Figure 6a. Here, the
isotopologues to the right and to the left of the base peak are lower for the hypothetical distribution
than for the experimental distribution. The net effect is that there is a greater RMSD difference
without a significant difference in predicted deuterium uptake. That is, the lower isotopologue
intensities on both sides of the base peak to some degree cancel out any contribution to m/z shift.
Such an experimental distribution could result from different populations of molecules
encountering different solution mixing efficiencies at the tip of the capillary. That is, the
experimental isotopic distribution could in effect be multimodal leading to higher intensities for
lower and higher isotopologues. Therefore, improvements in device design that would improve
the reproducibility of the mixing could result in improved parameterization and prediction.

2.3.7. Final Considerations of Rapid Solution-Phase HDX for Compound Identification
One concern of the approach is whether the HDX behavior of the compounds is reflective
of the type of mass spectrometer employed in the measurement. To test whether or not the HDX
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results are instrument specific, a number of compounds were subjected to cVSSI-MS analysis on
a LCQ Fleet (Thermo Scientific) instrument. Here, the intent was to compare with an instrument
having markedly less resolving power (3D ion trap) and containing a different MS inlet diameter
and length as well as different focusing optics in the first differential pumping stages. Figure 2-7
shows the isotopic distributions obtained for butylamine, 3-amino propanol, and homoserine. For
each of the ions, the relative ordering of isotopologue intensity is the same and of similar level as
that obtained from experiments performed on the orbitrap mass spectrometer. This suggests that
the rapid HDX approach is not dependent on a particular mass spectrometer instrument.
Additionally, it is noted that the usage of the internal standard should correct for differences in
inlet accessibility of other mass spectrometers.

Figure 2-7. Isotopic distributions of the [M+H]+ ions of butylamine from the (a) q-exactive hybrid
quadruple-orbitrap mass spectrometer (high resolution) and (b)LCQ Fleet Ion Trap (low resolution) ; 3Amino-propanol from the (c) q-exactive hybrid quadruple-orbitrap mass spectrometer (high resolution) and
(d) LCQ Fleet Ion Trap (low resolution); and, L-homoserine from the (e) q-exactive hybrid quadruple-orbitrap
mass spectrometer (high resolution) and (f) LCQ Fleet Ion Trap (low resolution). Spectra were obtained
after the compounds were exposed to D2O flow (see manuscript for details).
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It is instructive to consider the limitations of an approach in which isotopic distributions
obtained from HDX are used to identify compounds via database searching or isotopic distribution
prediction approaches. Although for the simple mixtures of standard compounds studied here
tandem mass spectrometry (MS/MS) and multistage tandem mass spectrometry (MSn) are not
required for compound identification, complex mixtures present a more significant challenge. The
clearest example of compounds that could not be distinguished by this approach is structural and
positional isomers. Such species would still require other indispensable measurement strategies,
such as chromatographic separation and/or MS/MS and MSn for accurate identification. That
said, such an approach demonstrated here may be able to distinguish a large number of functional
group isomers. Overall, the approach could be categorized among other strategies that have
proposed using solution HDX to provide information about the numbers of acidic hydrogens to
help narrow down candidate compounds [67, 68, 71]. A distinguishing feature of the approach
presented here is that, in addition to providing information about the overall number of acidic
hydrogens, it could also provide unique signatures based on the types and numbers of different
functional groups.
As mentioned above, this work is intended to expand upon other work with a focus of
developing a voltage-free ionization platform for metabolomics analyses. A concern that arises is
the ease with which it can be coupled with condensed-phase separations and its overall
sensitivity. A recent publication has demonstrated the coupling of cVSSI with reversed-phase
liquid chromatography. Remarkably, droplet production occurs over a very wide range of solvent
flow rates (nL min−1 to mL min−1) demonstrating facile coupling with various LC strategies.
Additionally, for a protein digest and a metabolite mixture, LC- cVSSI was observed to produce
ion signals that were ~ 10-fold lower than LC-ESI. Although this may seem significant, it is noted
that cVSSI has only been under development for ~ 6 months and with the degree of engineering
focused on ESI sources, the sensitivity of cVSSI is expected to increase. For example, two
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strategies currently under investigation are the use of smaller capillaries to produce smaller
droplets as well as the development of better MS inlet flow structures for improved droplet
entrainment. That said, at this early stage, the necessary sensitivity to conduct metabolomic
experiments currently exists, and these further studies show that HDX can be performed post LC
separation in the manner already demonstrated for metabolomics analyses [67, 68, 71].
As a final note, it is worthwhile to discuss the limitations imposed by the relatively small
compound cohort used to obtain the HDX P values. Notably from Eq. (2), it is apparent that P is
independent of i. That is, the HDX parameter is independent of select moieties on/within select
compounds. Thus, the accuracy of prediction may be improved by the measurement of the HDX
characteristics of a much larger sample cohort. In this manner, additional parameterization could
link functional groups to specific compounds, molecular cores, or structural motifs that would allow
for improved compound discrimination.

2.4. Conclusion
Proof-of-concept experiments employing rapid solution-phase HDX have been performed
for 18 model compounds. A new ionization technique termed capillary cVSSI is demonstrated to
achieve HDX levels that are more extensive than those accomplished with n-ESI using a theta
capillary approach. The isotopic distributions of ions of the model compounds obtained after HDX
are observed to be highly reproducible and it is suggested that an optimized approach may be
used in the future to aid compound identification. This would be accomplished with an isotopic
distribution matching approach similar to EI spectral matching. Additionally, a new approach for
predicting the deuterium uptake or the isotopic distributions for new com- pounds (e.g., newly
emerging drugs) using hydrogen type parameterization is presented. At this very early stage, on
average, a more than two-fold improvement in deuterium up- take prediction accuracy is realized.
For a number of compounds, this improvement is significantly higher. Although the early results

51

are encouraging, further improvements to the method require significant work in experimental
measurements and device design.
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3.1 Introduction
Carbohydrates are the most abundant class of organic compounds found in living
organisms [1–5]. The biological roles of these carbohydrates appear to span the spectrum from
those that are trivial, to those that are crucial for the development, growth, function and thus
survival of an organism [1, 6, 7]. In addition to sugars and starches playing vital nutritional roles,
carbohydrates have other functions such as cell adhesion, cell signaling, maintaining structural
integrity

and

regulation

of

biochemical

pathways

[8,9].A

high-throughput

structural

characterization is proving to be challenging because these compounds are highly diverse as they
occur in nature as heterogeneous mixtures which are highly complex [4, 8, 10]. The diversity is
attributed to the fact that, although carbohydrates are only made up of 20 common
monosaccharides, they may be linked together via five potential positions. Additionally, there are
two possible anomeric configurations (α and β) and some monomer units have different ring sizes
(e.g., furanose has five rings whilst pyranose has six [10–12]. This gives rise to numerous
carbohydrate isomers and therefore, a complete structural characterization of carbohydrates
would require information on linkage, branching, as well as anomeric configuration.
Three-dimensional geometric assignments of carbohydrate structures can be obtained
from nuclear magnetic resonance spectroscopy (NMR) [13–15] or crystallography [10, 15, 16]
These techniques are limited in providing a high-throughput analysis[ 10, 15]. Crystallography is
limited in that it requires the production of a crystal of the isolated carbohydrate. NMR typically
requires larger samples (milligrams). Mass spectrometry (MS) has been a widely used strategy
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for carbohydrate and glycoconjugates analysis because of its overall speed and sensitivity [11,
17]. Unlike proteins, there is no database to search against all possible carbohydrate structures
and therefore the characterization of carbohydrates fully depends on the details obtained from
the mass spectra [8]. MS as a standalone technique is limited for complete characterization of
carbohydrates, hence there is need for development of orthogonal measurement techniques [18].
Liquid chromatography-mass spectrometry (LC-MS) [19–22] and capillary electrophoresis (CE)
[7, 23, 24] have been widely used for characterization of carbohydrates but the techniques are
still limited in the separation of isomeric species. Here it is noted that carbohydrates have very
different biological activities due to subtle differences which arise because of isomerism and
chirality [6]. This makes a complete structural analysis for these molecules even more demanding
and places a greater urgency on the development of complimentary techniques for full
characterization.
Mass spectrometry combined with tandem MS (MS/MS) has been widely used for the
elucidation of carbohydrate isomeric structures [11, 17, 25–27]. Collision-induced dissociation
(CID) primarily occurs via glyosidic bond cleavages providing useful information on anomerocity
and the type of linkage [25, 28, 29]. Electron capture dissociation (ECD) [30, 31] and electron
transfer dissociation (ETD) [29, 32] produce additional cross-ring fragments useful for linkage
position information. More recently, charge-transfer dissociation (CTD) has been shown to
provide highly informative fragments for carbohydrate ions [33]. That said much of tandem MS is
still limited in that many fragments may be isobaric and, in most cases, have similar intensities
[29]. Thus, no specific structural information can be obtained based on the differences in
intensities of the fragments. Ion mobility spectrometry-mass spectrometry (IMS-MS) has been
widely used to investigate carbohydrate isomers [3, 10, 29, 34–36]. IMS-MS is proving to hold
significant potential for differentiation of isomers as it provides a means to separate gas-phase
ions based on their shape-to-charge ratio. When combined with fragmentation techniques the
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collisional cross section (CCS) values for isomeric fragment ions obtained are often different and
can be useful as a means for distinguishing the isomeric precursors [10]. Different combinations
of IMS-MS and CID methodologies have been used in an effort to establish a CCS library of
carbohydrate precursor and fragment ions[10, 37, 38]. This has the potential for use in
distinguishing carbohydrate isomers because of inherent high-throughput sequencing
capabilities.
Hydrogen deuterium exchange-mass spectrometry (HDX-MS) is now widely used in
carbohydrates and glycoproteins analysis [18, 39–44]. Solution HDX exchange rates are dependent
on the pH and temperature of the solution, the presence of hydrogen bonding, charge location,
neighboring functional groups as well as solvent accessibility [41, 45] The rapid exchange experienced
by hydroxyl groups in carbohydrates makes solution-phase HDX-MS challenging [41]. Others have
demonstrated HDX of carbohydrate ions occurring in the electrospray ion source (in-ESI) [39, 40, 43,
46]. The deuterated solvent is introduced through various means including dual spray tips, as a curtain
gas, as a nebulizer gas and also by placing a droplet of D20 inside the source [41, 46, 47]. Uppal et al.
has previously demonstrated gas-phase hydrogen deuterium exchange to differentiate protonated
carbohydrate isomers [18], however, it was suggested that gas-phase HDX may not conserve native
conformations of carbohydrates at the end of an electrospray process [41]. Therefore, solution-phase
HDX may present a more useful characterization of solvated structures especially in an effort to
distinguish carbohydrate isomers.
Advances in ionization techniques have made it possible to investigate oligosaccharide
structures by a range of MS technique .There are many methods for biomolecular ionization but
the most commonly used are matrix-assisted laser desorption ionization (MALDI) [48, 49] and
electrospray ionization (ESI) [50]. The most common studies for oligosaccharides with ESI have
focused on experiments carried out for positively-charged ions (positive ion mode) via protonated
ions or those forming adducts with metal ions from group 1, group 2 and first row transition metals
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[39, 49, 51, 52]. It has been demonstrated that lithium ions have a tendency to ionize
oligosaccharides efficiently and in addition the fragments derived from cross-ring cleavages
provide linkage information [51, 53]. Fewer studies have been performed to analyze
oligosaccharides in negative ion mode and this simply results from neutral oligosaccharides
tendency to exhibit decreased formation of [M-H]- ions because of the lack of highly acidic groups
[51, 54].
The advent of nanoelectrospray ionization (nESI) employing flow rates < 100 nl/min has
considerably extended the usability of ESI-MS in many analytical areas [55, 56]. Some reports
have demonstrated that the use of nESI can improve the sensitivity of oligosaccharides ion
signals in MS [56]. Capillary vibrating sharp edge spray ionization (cVSSI) is a new ionization
technique that works by nebulizing liquid samples through the vibration of a glass capillary to
generate ESI-like mass spectra [39, 57–59]. In recent work, a significant improvement in the
ionization of compounds in negative ion mode has been demonstrated using cVSSI [60]. This
new method has shown great utility for native MS analysis as the method has been demonstrated
for the analysis of compounds from 100% aqueous solutions. Overall, Li et al demonstrated a 10
to 100-fold enhancement in signal intensity and 3 to 10-fold improvement in signal-to-noise ratio
S/N for oligosaccharides, DNA, proteins and peptides [60].
In previous studies which were inspired by the work of Zare and coworkers [67], rapid
solution-phase HDX has been demonstrated as a means for distinguishing small-molecule
metabolites[58].In these studies a single cVSSI device with two glass capillary tips (ID 100 μm)
attached side by side on a glass slide were utilized. These experiments provided an ability to
conduct on-line HDX prior to mass analysis for metabolite compound identification. The work
presented here extends the utility of the previous method by developing a novel
ionization/reaction platform for MS known as dual capillary vibrating sharp-edge spray ionization
dual-cVSSI. This platform can easily interface with continuous-flow separations generating nESI62

like mass spectra without the use of multiple high voltage applications or requiring a nebulizing
gas. The dual device setup (see below) provides a platform to conduct fast, on-line HDX. One
application of the rapid HDX is its potential to distinguish isomers, which are not resolvable by MS
alone. This work examines the ability of in-droplet HDX to distinguish monosaccharide
stereoisomers and disaccharide isomers having the same linkage as well as linkage trisacharides
isomers.

3.2 Experimental
3.2.1. Chemicals and Solvents
Monosaccharide standards, N-Acetylglucosamine (GlcNAc), N-Acetyl-D-galactoseamine
(GalNAc) and N-Acetyl-D-mannoseamine (ManNAc), were purchased from Sigma-Aldrich (St.
Louis, MO, USA) .The disaccharides lactulose (≥ 98.0% HPLC); turanose (≥ 98.0%); nigerose (≥
90.0% HPLC); sophorose (≥ 98%); sucrose ((≥ 98.0%); gentibiose (≥ 85% remainder primarily αanomer); melibiose (≥ 98.0% HPLC); and, Palatinose (≥ 99% Hydrate) were obtained from SigmaAldrich (St. Louis, MO, USA). Cellobiose (Research standard) was obtained from Thermo Fisher
Scientific. The two glycans isomers, 2-Fucosyllactose and 3-Fucosyllactose were purchased from
Biosynthesis Carbosynth. Optima® LC/MS grade water was purchased from Fischer Chemical
(New Jersey, NJ, USA). Deuterium Oxide (99.9 atom percentage D) was purchased from SigmaAldrich (St. Louis, MO, USA). All standards were used without further purification. Table 3-1
provides the chemical names, molecular formulas, molecular weights and structures for all
carbohydrates examined in this study.

3.2.2. Sample Preparation
For dual spray capillary-based experiments, all monosaccharides, disaccharides and
glycan samples were prepared as standard stock solutions of concentration 1 mg/ml in LC-MS
grade water. Homoserine was used as an internal standard and mixed with each standard solution
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to give a final concentration of 0.01 mg/ml and 0.1 mg/ml of homoserine and carbohydrate
standard respectively.

Table 3-1 Names and structures of carbohydrates
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a

Names of the compounds

b

Structural representations of the compounds drawn using the Chem Drawer software suite

For single spray cVSSI experiments, single standard solutions of the disaccharides in LC-MS
water were mixed with deuterium oxide D2O to give a final concentration of 0.1 mg /ml of the
standard carbohydrates and 0.01 mg/ml of the homoserine internal standard. All solutions were
prepared fresh daily for each experiment.

3.2.3. Construction of the cVSSI Device
A detailed description of cVSSI fabrication has been presented elsewhere[57–59, 61]
Briefly cVSSI devices were assembled by attaching a piezo electric transducer (7BB-27-4 L0,
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Murata diameter=27 mm) on one end of the number 1 glass slide coverslip (w x 1 = 25 x 60 mm)
(VWR, Radnor, PA, USA) using epoxy glue. A fused-silica pulled-tip capillary (360 nm OD x 100
nm ID), approximately 5 cm in length was attached at a 60° counterclockwise angle to the distal
right corner of the microscope slide using glass glue, ensuring that the end of the tip is in line with
the center of the glass slide (Figure 3-1). The pulled capillaries were prepared using a LaserBased 150 Micropipette Puller Sutter P-2000 (CA, U.S.A.) and were soaked in 30% hydrofluoric
acid for ∼5 minutes before attachment to the glass slide. The end internal diameter (I.D) of the
pulled capillary was measured under a microscope and only tips with similar end I.D. values (20
to 30μm) were used in all experiments. A ∼20 cm tube (PTFE) connector was constructed by
attaching a 5 cm nichrome-60 wire; this was accomplished by puncturing a shallow hole 2 to 3
inches from one end, inserting the nichrome wire, and sealing it with epoxy glue. In the final
setup, one end of the tube connector was attached to a precision needle (BD 0.3 mm x 13 mm)
on one end of the tubing and the other end was slip fit over the pulled-tip capillary.

3.2.4. Dual Capillary Vibrating Sharp-edge Spray Ionization (cVSSI)

The dual-cVSSI platform consists of two separately controlled cVSSI devices with emitter
tips. Each device was connected to a syringe (BD 1 mL) via the precision needle (see above and
Figure 3-1). Pumping of the solutions was performed using a Chemyx Fusion 4000 multi-channel
syringe pump (Chemyx, Stafford, TX, USA) which is equipped with two independently controlled
precision syringe pump channels with programmable step-rate functionality. For all experiments,
a constant flow rate of 5 μL/min was maintained for both the analyte and the D2O reagent. The
two devices were placed at a 90-degree angle with respect to each other and approximately 0.5
to 1 cm from the inlet of the mass spectrometer as shown in Figure 3-1. This results in rapid,
online HDX due to the mixing of droplets emerging from the two tips just prior to introduction into
the mass spectrometer through the inlet capillary (ID 0.5 cm).
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cVSSI
High voltage

Nichrome wire
Glass slide
Piezoelectric transducer
Amplifier
Waveform
generator

0.5-1cm
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Pulled capillary

Plastic tubing
Nichrome wire
High voltage

Figure 3-1. Schematic representation of the dual capillary cVSSI setup for on-line HDX reactions of
monosaccharide, disaccharide and trisaccharide isomers. Component parts are labeled. Headings indicate
hyphenated instruments parts.

A new cVSSI device and new tubing for the analyte was used for each experiment to
minimize the effects of carryover from the previous carbohydrate sample. However, the positions
of the devices were held constant to maintain the same distance from the MS inlet. The two cVSSI
devices were activated with a Tektronix function generator (AFG- 1062, Tektronix, Beaverton,
OR, USA) which was connected to an amplifier (Krohn-Hite 7500, Brockton, MA, USA). Optimum
conditions that produce a stable plume and provide the greatest ion signal intensities were
investigated. The operational scanning frequency and amplitude of the RF signal used for both
devices were between 100 to 150 kHz and 5 to 10 Vpp. For positive ion mode experiments,
positive potentials of 0.2 kV and 1.5 kV were applied to the D2O device and analyte device,
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respectively via the nichrome wire inserts with two independent high-voltage power supplies. For
negative ion mode experiments, negative potentials of 0.2 kV and 1.5 kV were also applied to the
D2O device and analyte device, respectively.

3.2.5. Single Spray cVSSI Experiments

The single standard solutions of the disaccharide and homoserine (internal standard) at
0.1 mg/ml and 0.01 mg/ml, respectively were analyzed using only an analyte device (Figure 3-1).
The device was placed at the entrance of the mass spectrometer approximately 0.5 to 1 cm from
the inlet. All disaccharides were analyzed in negative ion mode. A negative potential difference of
1.5 kV was applied via the nichrome wire connection in a similar manner to the dual cVSSI
experiments.

3.2.6. Mass Spectrometer Analysis

A Q-Exactive hybrid quadrupole-orbitrap mass spectrometer (Thermo Fisher, San Jose,
CA) was utilized for all the dual cVSSI experiments. This instrument features a 5-inch long
heated inlet capillary (0.058 inch I.D.). The instrument features accurate-mass (HR/AM) Orbitrap
detection with precursor ion selection using high resolution. The resolving power was set to
70,000 for all Full MS scans. Experiments for monosaccharides were conducted in both positive
and negative ion modes. All experiments for disaccharides and glycans were conducted in
negative ion mode using a m/z scan range of 50-500 (1 micro scan). The AGC target was set to
5×105 and the inlet capillary temperature was maintained at 275 °C. To ensure that there was
no residual carbohydrate isomer and D2O, a 50/50 methanol and water mixture was infused
between each run for ~ 2 minutes.

Samples were analyzed in random order for each separate day. A single data acquisition
was recorded for the monosaccharides data (Figure 3-2 and Figure 3-3); all disaccharides and
69

trisacharides data were collected in triplicate measurements by simply turning on and off the data
acquisition software . This was done to examine the HDX variability and instrument’s performance
over more extended times. Ion chronograms were collected for ~1 minute. The last datasets
(Figure 3-4) were collected by completely switching off the substrate vibration, the flow rates and
the applied voltage between each measurement. All data for the single cVSSI experiments were
collected on a LTQ-XL mass spectrometer (Thermo Fisher, San Jose, CA, U.S.A.). The cVSSI
device was placed 0.5 to 1 cm from the inlet of the mass spectrometer. The same parameters
(temperature and scanning range) used on the orbitrap were also maintained on the LTQ-XL
instrument.

It has been suggested that during the infusion of a mixture of an analyte solution and D2O
into the mass spectrometer, a significant back exchange occurs due to interaction with trace
amounts of water vapor [62, 63]. This back-exchange is argued to remove almost all deuterium
labels resulting in a binomial isotopic distribution with a maximum close to the monoisotopic
peak[63]. To minimize any back exchange reaction for these experiments, the ionization source
was saturated with D2O vapor before each run [63].

3.2.7. Experimental Deuterium Uptake Determinations

When exposed to the deuterated solvents, the mass increase experienced by the ions
resulted from hydrogens on the hydroxyl groups being replaced with deuteriums. The amount of
deuterium incorporated is determined based on the shift in average m/z values between the
compound’s ions before and after the addition of D2O. This was calculated using the weighted
average of isotopologue features for the unreacted and HDX product ions using an in house
script. For the monosaccharide, disaccharide and trisaccharide measurements collected in
triplicate, the average deuterium uptake was computed. For the bar graphs (Figure 3-2 to Figure
3-4), the average isotopologue peaks were scaled to the base peak. Relative Standard Deviation
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RMSD values calculated for all carbohydrate samples were less than 20%. For a summary of
deuterium uptake for all carbohydrates and the corresponding homoserine internal standards see
Table 3-2.

3.2.7 Principal Component Analysis
A principal component analysis was utilized to establish the distinguishing ability of the
isotopic patterns for all disaccharides with different linkages. The PCAGO software, an online
web tool, was utilized for the principal component analysis.[64]. First the raw data was placed into
an Excel (Microsoft) spreadsheet and a 16 x 6 matrix containing the sample runs and the
normalized isotopologue intensities (expressed as a percentage and rounded to the nearest
integer) was created as a comma delimited text file. For these analyses, intensity values for the
D0, D1, D2, D3, D4, and D5 isotopologues for each run were used. This intensity data was
uploaded into the PCAGO website. The first data processing step was a normalization (DESeq2)
using the median of ratios. To conduct the PCA the data was centered to shift the mean of the
intensities to zero and the data was centered (i.e. scaling of the variances of the intensities to 1).
From the output file, the PC1 and PC2 components were visualized on a scatterplot.

3.3. Results and Discussion
3.3.1 Dual-capillary cVSSI Experiments
Following fabrication of the device, optimization of the operational parameters was
conducted. The first parameters to be optimized were the RF signal frequency and amplitude.
These parameters were necessarily varied for the evaluation of sufficient nebulization at the
capillary tip. The operational range of the RF frequency and amplitude for both the devices in the
dual cVSSI setup had to be in the same range as their application was achieved with a single
input using a switch box (Figure 3-1). When the optimal parameters were obtained for consistent

71

liquid nebulization at the tip of the capillary, the frequency and amplitude were recorded on the
device for subsequent use in MS analyses. The ability of the cVSSI devise to generate droplets
that could sufficiently combine while en route to the MS inlet was also investigated. It was
observed that a flow rate of 5 μl/min for both the deuterated solvent and the analyte was the
optimum setting. An increase in the flow rate of either the solvent or the analyte resulted in
significantly larger droplets that would cause instability in droplet mixing. Emitter tip orifices
outside the range 20 to 30 μm I.D produced smaller or larger droplets that also did not mix well.
Larger droplets resulted in the accumulation of a large droplet on the D2O device that was closest
to the entrance of the mass spectrometer. The final parameter to be optimized was the voltage.
Voltages of the same polarity were used to avoid droplet accumulation on either device; a
significantly lower voltage was applied to the D2O device to enhance droplet mixing. Any change
in the flow rate(s) required a change in the applied voltages to avoid a buildup on either device.
The best conditions for conducting the in-droplet HDX studies are provided above (Experimental
Section).
The use of HDX reactions to distinguish carbohydrate isomers requires a method of mixing
that occurs on a very short time scale [65, 66]. Previously, Zare and coworkers have demonstrated
the

use of

theta capillaries for rapid HDX experiments [67]. Previous cVSSI work also

demonstrated rapid solution-phase HDX with dual capillary emitters [58]. In the previous work,
the dual capillary emitters were blunt and were positioned parallel to each other. This technique
allowed rapid reagent mixing because of the micrometer-sized droplets produced. This resulted
in compounds having unique isotopic distributions as a result of the differing amounts of deuterium
incorporated.
A question that arose from the prior work was whether the technique could be applied and
used to distinguish carbohydrate stereoisomers and linkage isomers. Carbohydrate isomers have
the same type and number of hydrogens (hydroxyl groups). However, these hydrogens could
have slightly different acidities in solution, making it possible to distinguish them with exchange
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reactions that are quenched on a faster time scale. This work was also inspired by the recent
study by the Li group, where a simple method to improve electrospray ionization efficiencies in
negative ion mode for 100% aqueous solutions was demonstrated [59]. The setup for the dual
capillary cVSSI (Figure 3-1) was modified to allow for turning on and off the D2O droplet production
independently from the analyte. In the previous cVSSI studies where the compounds had different
functional groups, some of the different heteroatom hydrogen types could easily be distinguished.
[58].
For the studies described here, the D2O device tip is placed much closer to the MS inlet.
This allowed the use of lower voltages such that the field experience by the analyte droplets was
not perturbed significantly. This arrangement also shortened the reaction times enabling a shorter
timescale reaction quenching to capture the differences in the rates of hydroxyl group HDX for
the disaccharide ions. The resulting unique isotopic distributions were used to distinguish both
stereoisomers and linkage carbohydrate isomers in this work. Another advantage of this platform
was that it utilized relatively low voltage applied to the analyte device, which is beneficial for
preserving native conformations of biological molecules.

3.3.2. Internal Standard
Previous studies by Kim et al. show that the rates of exchange for these rapidly
exchanging hydroxyl groups can be affected by the residual solvent vapors that accumulate inside
the source [41]. Liyanage et al., have demonstrated that by applying an internal standard in
studies examining carbohydrates with metal adducts, the repeatability of in-ESI HDX could be
improved [39]. Gutman et al. also reported that the incorporation of an internal standard should
facilitate the production of reproducible exchange profiles as it can correct for any offsets with
instrument conditions [18]. Additionally, it was noted that the usage of the internal standard should
correct for differences in inlet accessibility when using different mass spectrometers [41]. In the
work presented here, the dual cVSSI experiments, homoserine was used as an internal standard.
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The exchange levels for hydroxyl groups on carbohydrate ions may vary according to different
conditions (source conditions, ambient humidity, etc.). To ensure reproducibility in these
experiments, only cVSSI devices having similar inner diameters (20 to 30um) were used.
Additionally, efforts were made to maintain the same distance (0.5 to 1 cm) from the device emitter
tips and the inlet of the mass spectrometer. It was also very crucial that the 90o angle between
the two devices be maintained during the measurements

For negative ion mode analysis experiments, the [M-H]- homoserine ion has three
exchangeable hydrogens. For positive ion mode analysis, the [M+H]+ homoserine has five
exchangeable hydrogens. As demonstrated in prior work[58], it appears that these different types
of hydrogens have different deuterium exchange rates. For both sets of experiments, four
isotopologues were observed when employing the optimum conditions previously discussed.
Admittedly, for some experiments the positions of the devices had to be maneuvered slightly to
ensure that the same exposure to D2O by the analyte was achieved.
With minor position adjustments, the isotopic distributions for the homoserine internal
standard show a relatively high reproducibility for different devices on different days. For this
prototype design, such reproducibility was deemed to be sufficient to conduct the comparison
experiments. Figure 3-2g and Figure 3-4a show the scaled (to the base peak) isotopologue
intensities in positive ion mode experiments on different days for the internal standard. Overall,
the D0, D1, D2 and D3 isotopologues were observed. In negative ion mode, the same number of
isotopologues was also observed (Figure 3-3g and Figure 3-4c). Typically when employing the
optimum droplet mixing conditions, good analyte HDX reproducibility (RSD + 10%) was observed
when the D1 isotopologue for homoserine was between 40 and 50% of the peak height of the D0
isotopologue. The differences observed for the intensities of the D1 isotopologues could be
attributed to small differences in the cVSSI emitter tip diameter used for each experiment. That
is, the different devices could produce droplet size distributions that are slightly different which
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may affect the mixing efficiencies. In addition, it may be attributed to the change in cVSSI device
for each experiment which could result in slight location differences. Overall however, the patterns
of the isotopic distributions, were quite consistent even when collected days apart over a period
of several weeks.

Table 3-2. Deuterium uptake for all carbohydrate isomers
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3.3.3 Monosaccharides-specific HDX Behavior

To evaluate the utility of solution phase HDX in distinguishing isomers, we first examined
the HDX patterns of diastereomeric N-acetylhexosamine monosaccharides namely: NAcetyleglucosamine (GlcNAc), N-Acetylgalactosamine (GalNAc), and N-Acetylmannosamine
(ManNAc). These three compounds are stereoisomers. The GlcNAc structure has C2 and C4 on
the equatorial position while the GalNAc structure has C2 on the equatorial and C4 on the axial
position. Finally, the ManNAc has C2 on the axial and C4 on the equatorial position [68] (Table
3-1). These three compounds have previously been distinguished using gas-phase HDX with ND3
using ion mobility spectrometry- mass spectrometry[18]. The isotopic patterns obtained upon HDX
were demonstrated to be distinct with deuterium uptake values reported for GlcNAc, GalNAc, and
ManNAc being 3.91 ± 0.04, 3.44 ± 0.02, and 3.78 ± 0.03, respectively.

The work presented here also demonstrated that a change in stereochemistry can alter
the HDX isotopologue pattern for the monosaccharides. First, the [M+H]+ ions were observed by
protonating the secondary primary amine group attached to the ring. The HDX isotopic
distributions for the three monosaccharides are somewhat distinct as labile hydrogens appear to
undergo rapid exchange at different rates. Figure 3-2 shows the expanded mass spectrum for the
monosaccharides. Figure 3-2b, Figure 3-2d and Figure 3-2f show the expanded region for
GlcNAc, GalNAc, and ManNAc, respectively. Figure 3-2a, Figure 3-2c and Figure 3-2d show the
corresponding expanded regions of the mass spectrum for the homoserine internal standard.
GalNAc ionizes well and displayed the highest signal intensities (~1.48×105). ManNAc has the
least ion signal intensity as it did not ionize as well yet it displayed the greatest HDX compared
with GlcNAc and GalNAc.
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Figure 3-2. Expanded regions of the mass spectra representing experimental isotopic distributions for
[M+H]+ ions of three isomeric monosaccharides. The data were obtained with the dual cVSSI setup and the
Q-Exactive hybrid quadrupole-orbitrap mass spectrometer. Panels (a), (c) and (e) show mass spectra for
the homoserine internal standard in the N-Acetyleglucosamine (GlcNAc) (b), N-Acetylgalactosamine
(GalNAc) (d) and N-Acetylmannosamine (ManNAc) (f) samples, respectively. Bar graphs provide the
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experimental isotopic distributions of the scaled (to the base peak) intensities. Bar graph (g) shows the
isotopic distribution for the homoserine internal standard where dark blue, dark red and dark grey bars
correspond to GlcNAc, GalNAc and ManNAc samples, respectively. Bar graph (h) depicts the isotopic
distributions of GlcNAc (dark blue), GalNAc (dark red) and ManNAc (dark grey). Molecular weights and
structures for the compounds are provided in Table 3-1.

This same trend is also shown in the bar graph (Figure 3-2h) which shows the normalized
intensities for triplicate measurements. The respective homoserine internal standards Figure 32g, show similar levels of exchange as revealed by the isotopologues except in the GalNAc
experiment where the D2 isotopologue shows a slightly higher intensity. However, the
corresponding D1, D2, D3, and D4 isotopologues for the monosaccharides show that they were
of higher intensities for GalNAc compared to the respective isotopologues of the other isomers.
Despite the internal standard for the GalNAc sample having more HDX, this isomer showed the
least amount of exchange. The deuterium uptake for the three isomers is shown in Table 3-2

The behavior of the monosaccharides was also investigated in negative ion mode. The

[M-H]- ions were generated by deprotonation of the hydrogen on one of the hydroxyl groups. All
settings for data collection from the positive ion mode experiments were maintained in the latter
experiments except for the polarity of the voltage applied to the cVSSI devices. Figure 3-3b,
Figure 3-3d and Figure 3-3f show the expanded regions of the mass spectra for the
monosaccharides GlcNAc, GalNAc, and ManNAc respectively. Figure 3-3a, Figure 3-3c and
Figure 3-3d show the corresponding expanded regions of the mass spectra for the corresponding
homoserine internal standards. Similar to the positive ion mode data, GalNAc ionized well and
provided the highest signal intensities. ManNAc yielded the highest deuterium uptake for all
isotopologues (D0, D1, D2, D3, and D4).
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Figure 3-3. Expanded regions of the mass spectra representing experimental isotopic distributions for
three isomeric monosaccharides [M-H]- monosaccharide ions of three isomers obtained with dual capillary
cVSSI with Q-Exactive hybrid quadrupole-orbitrap mass spectrometer. Panel (a), (c) and (e) show mass
spectra for the homoserine internal standard in the GlcNAc (b), GalNAc (d) and ManNAc (f) samples,
respectively. Bar graphs provide the experimental isotopic distributions of the scaled (to the base peak)
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intensities. Bar graph (g) shows the isotopic distribution for the homoserine internal standard where dark
blue, dark red and dark grey bars correspond to GlcNAc, GalNAc and ManNAc samples, respectively. Bar
graph (h) depicts the isotopic distributions of GlcNAc (dark blue), GalNAc (dark red) and ManNAc (dark
grey). Molecular weights and structures for the compounds are provided in Table 3-1.

This trend is shown in the isotopologue bar graph (Figure 3-3h) which shows the scaled intensities
for triplicate measurements. The homoserine internal standard in the GalNAc sample (Figure 33g) shows a higher D2O level; however, the corresponding D1, D2, D3, and D4 isotopologues
intensities for the monosaccharide ions show that ManNAc has the highest intensities compared
to the other isomers. The deuterium uptake for the three isomers are shown in Table 3-2.

It is interesting to note that the isotopic distributions in negative ion mode (Figure 3-3)
follow the same trends as observed in positive ion mode (Figure 3-2). Generally, for both positive
and negative ion modes, the order of deuterium uptake is GlcNAc < GalNAc < ManNAc. Notably,
there is a 2-fold increase in the signal intensity in negative ion mode compared with the positive
ion mode experiments. This is similar to demonstrated enhancements in ion signal intensity for
microflow analysis of nucleotides analyzed in negative ion mode[69]. Notably, Li et al. have also
demonstrated enhanced ion signals for DNA in negative ion mode with a similar cVSSI
experimental setup[59]. The amount of deuterium exchange is generally higher in positive ion
mode experiments compared to those in negative ion mode conducted at the same flow rates
(See Table 3-2). In part, this arises because of the difference in numbers of available hydrogens
between the protonated and deprotonated ion species. Therefore, only four hydrogens are
available for negative ion mode compared to six hydrogens in positive ion mode. This preliminary
data suggests that a change in stereochemistry at just a single position in isomers is sufficient to
alter the solution HDX reactivities.
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Figure 3-4. Bar graphs presenting experimental isotopic distributions of the normalized intensity values
for three pairs of isomeric monosaccharides obtained with dual cVSSI experiments employing a Q-Exactive
hybrid quadrupole-orbitrap mass spectrometer on a separate day. Bar graph (a) and (b) show isotopic
distributions in positive ion mode [M+H]+ ions. Bar graph (a) shows the isotopic distribution for the
homoserine internal standard where dark blue, dark red and dark grey bars correspond to NAcetyleglucosamine (GlcNAc), N-Acetylgalactosamine (GalNAc) and Acetylmannosamine (ManNAc)
experiments, respectively. Bar graph (b) depicts the isotopic distributions of GlcNAc (dark blue), GalNAc
(dark red) and ManNAc (dark grey). Bar graph (c) and (d) show the respective isotopic distributions in
negative ion mode. Molecular weights and structures for the compounds are provided in Table 3-1.

The reproducibility of the HDX isotopic distributions was also examined with regard to the
usage of different devices, different sample solutions as well as different environmental
conditions. HDX experiments were carried out over the course of several weeks on a different
day spaced apart by several weeks and the results showed good consistency in the isotopic
distribution patterns. Figure 3-4 shows the isotopic distribution for the monosaccharides from both
positive and negative ion mode experiments for these later studies. Figure 3-4a and Figure 3-4b
show lower HDX exchange for the homoserine internal standard compared to Figure 3.2g and
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Figure 3-3g. The D2 isotopologues for the internal standard (Figure 3-4c) were barely visible for
the second day experiments; this was reflected in the corresponding monosaccharides
isotopologues D3 and D4 (Figure 3-4d). However, it is noteworthy that for the different days, the
isotopic distributions were relatively similar with regard to the ordering of HDX reactivity on this
different day. Presently, it is not clear why there was an overall decrease in HDX from the first
experiments to the second experiments. It is possible that the emitter tip of the analyte or the
D2O reagent was not producing the same size droplets despite the best efforts to maintain all
parameters constant. That said, that the relative ordering of the monosaccharides in terms of
overall deuterium uptake as well as the production of different isotopic distributions was consistent
is

encouraging.

Finally, it should be noted that the error bars in Figure 3-4 represent

measurement reproducibility when the cVSSI devices are turned off and the liquid accumulates
at the tip between each acquisition. This is different than the other experiments (Figure 3-2 and
Figure 3-3) which just show three consecutive acquisitions. Table 3-2 shows the deuterium uptake
for the data in Figure 3-4

3.3.4. Disaccharides-specific HDX Behavior

To further investigate the utility of this method, the study was extended to disaccharide isomers.
The differences in the isotopic distributions within the same linkage isomers as well as across
different linkage isomers was studied. Overall four pairs of linkage disaccharide – (1→2), (1→3),
(1→4) and (1→6) – isomers were studied.

82

9.60E+04

0.00E+00

117

Total Ion Count (a.u)

Total Ion Count (a.u)

(a)

1.10E+05

118

119

120

121

122

(c)

5.50E+04

0.00E+00

Normalized Intensity
(Arbitrary Units)

117

2.80E+04

118

119

120

121

122

0.00E+00

m/z

340 341 342 343 344 345 346 347 m/z
1.90E+04

(d)

9.50E+03

0.00E+00

m/z

(e) D0

(b)

1.40E+04

Total Ion Count (a.u)

Total Ion Count (a.u)

1.92E+05

340 341 342 343 344 345 346 347

(f)

D0

D1

D3

D1

D4

D2

D5

D3
118

119

m/z

D2

120

121

341

342

343

344

345

346

m/z

Figure 3-5. Expanded regions of mass spectra representing experimental isotopic distributions for two
[M-H]- disaccharide ions from 2 isomers obtained with dual cVSSI employing a Q-Exactive hybrid
quadrupole-orbitrap mass spectrometer. Panel (a) shows the mass spectrum of the homoserine internal
standard corresponding to the sucrose (b) data. Panel (c) shows the homoserine distribution corresponding
to the sophorose (d) data. Bar graphs present experimental isotopic distributions for the scaled (to the base
peak) isotopologue features. Bar graph (e) shows the distribution for the homoserine internal standard (dark
blue) corresponding to the sucrose sample and homoserine (dark red) corresponding to the sophorose
sample. Bar graph (f) shows the isotopic distributions of sucrose (dark blue) and sophorose (dark red).
Molecular weights and structures for the compounds are provided in Table 3-1.
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3.3.4.1. (1→2) Linkage

Sucrose is a common sugar composed of the two monosaccharides glucose and fructose.
The two components are linked via an ether bond between the C1 on the glucosyl subunit and
the C2 on the fructosyl subunit (Table 3-1). Unlike most disaccharides, the glycosidic bond for
sucrose is formed between the reducing ends of both glucose and fructose and not between the
reducing end of one and the non-reducing end of the other. The disaccharide is a non-reducing
sugar since it contains no anomeric hydroxyl groups. Conversely, sophorose is a reducing
disaccharide formed between glucose units via a β linkage to the anomeric carbon of a galactose
subunit.

Figure 3-5b shows the isotopic distribution for sucrose and Figure 3-5d shows that for
sophorose. The isomers ionize to a relatively similar level as shown by the ion total counts of
2.80×104 and 1.90×104 for sucrose and sophorose, respectively. Having similar levels of
homoserine exchange, the disaccharide (Figure 3-5a and Figure 3-5c) isotopic distribution
patterns for the sucrose (Figure 3-5b) and sophorose (Figure 3-5c) are remarkably distinct. Figure
3-5f shows a bar graph with the scaled intensities for the isotopologues (triplicate measurements).
Figure 3-5g shows the corresponding isotopic distributions for the homoserine internal standard.
The dominant isotopologue in sucrose was D2, followed by D1 D3, D0, D4 and finally D5 in order
of decreasing intensity. Sophorose showed a different isotopic distribution pattern; overall, less
exchange was observed compared to sucrose, an isomer with the same glycosidic linkage. The
dominant isotopologue for sophorose is D0, followed by D1, D2, D3, D4 and D5 (Figure 3-5f).
Deuterium uptake for the sucrose and sophorose samples are shown in Table 3-2.

84

(b) D0

Normalized Intensity (Arbitrary Units)

(a) D0

D1

D2
D3

D1

D4

D2

D5

D3
(c) 118

119

118

119

120

120

121 (d) 341

342

343

344

345

346

341

342

343

344

345

346

121

m/z

Figure 3-6. Bar graphs presenting experimental isotopic distributions for isomeric [M-H] - disaccharide ions
(triplicate runs) obtained with dual cVSSI using the Q-Exactive hybrid quadrupole-orbitrap mass
spectrometer. Bar graph (a) shows the isotopic distribution for the homoserine internal standard (dark blue)
corresponding to the sucrose dataset and the homoserine (dark red) corresponding to the sophorose
dataset. Bar graph (b) shows the isotopic distribution of sucrose (dark blue) and sophorose (dark red). Bar
graph, (c) and (d) are the same as (a) and (b) obtained from data collected on a different day.

In a separate set of experiments, the positioning of the cVSSI devices was changed so
that there was less D2O available for exchange. Interestingly, with less deuterium uptake recorded
for the homoserine internal standard (Figure 3-6c) there is a significant mass shift in the isotopic
distribution for sucrose (Figure 3-6d). The major isotopologue becomes the D1 feature compared
to the D2 (Figure 3-6b). The next most intense isotopologues in order of decreasing intensities
are D0, D2, D3, and D4 (D5 is hardly observed). This is significantly different than the higher
exchange data (Figure 3-6b). Notably, although the lower exchange conditions do decrease the
overall deuterium incorporation by sophorose, the ordering of isotopes by intensity does not
change.
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Figure 3-7. Expanded regions of the mass spectra representing experimental isotopic distributions of
[M-H]- disaccharide ions of two isomers obtained with dual cVSSI employing with a Q-Exactive hybrid
quadrupole-orbitrap mass spectrometer. Panel (a) shows the mass spectrum of the homoserine internal
standard corresponding to the nigerose (b) dataset. Panel (c) shows the mass spectrum of homoserine
corresponding to the turanose (d) dataset. Bar graphs represents experimental isotopic distributions (scaled
intensities). Bar graph (a) shows the homoserine internal standard (dark blue) data corresponding to the
nigerose sample and homoserine (dark red) corresponding to the turanose sample. Bar graph (b) shows
the isotopic distributions of nigerose (dark blue) and turanose (dark red). Molecular weights and structures
for the compounds are provided in Table 3-1.
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3.3.4.2. (1→3) Linkage

Figure 3-7b and Figure 3-7c show expanded regions of mass spectra containing the
isotopic distributions for nigerose and turanose respectively. These two disaccharides are both
(1→3) linkage type isomers and their structures are shown in Table 3-1. nigerose is composed of
two alpha glucose monomers linked with a (1→3) glycosidic linkage and turanose is a reducing
disaccharide with a (1→3) linkage consisting of a glucose and a fructose monomer. Figure 3-7f
shows the scaled (to the base peak) intensities for the triplicate measurements. The
corresponding deuterium uptake for the homoserine internal standard is shown in Figure 3-7e,.
The respective deuterium uptake by each compound is shown in Table 3-2. Overall, nigerose has
a higher deuterium uptake compared to turanose. Additionally, nigerose shows an increased level
of HDX compared to turanose based on the differences in intensities of the ion isotopologues.
3.3.4.3. (1→4) Linkage
The disaccharide cellobiose is a reducing sugar consisting of two β-glucose molecules
linked by a β (1→4) glycosidic bond. Unlike cellobiose that has two β-glucose units, lactulose has
galactose and fructose connected with a β (1→4) bond (Table 3-1). The mass spectra showing
the isotopic distributions for cellobiose and lactulose are shown in Figure 3-8b and Figure 3-8d,
respectively. Figure 3-8f is a bar graph showing the scaled (to the base peak) intensities for
triplicate measurements. Deuterium uptake is shown in Table 3-2. Figure 3-8e shows the
corresponding homoserine isotopic distributions from each disaccharide’s dataset. The major
isotopologues for both disaccharides are D0 and the contributions from the other isotopologues
are D1, D2, D3, D4 and D5 in order of decreasing intensities. The isotopologues D2, D3, D4 and
D5 have higher intensities in cellobiose compared to those for lactulose (Figure 3-8f).
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Figure 3-8. Expanded regions of mass spectra representing experimental isotopic distributions for [MH]- disaccharide ions for two isomers obtained with dual cVSSI employing a Q-Exactive hybrid quadrupoleorbitrap mass spectrometer.

Panel (a) shows the mass spectrum of homoserine internal standard

corresponding to the mass spectrum of cellobiose (b). Panel (c) shows the mass spectrum of the
homoserine internal standard corresponding to the mass spectrum of lactulose (d). Bar graphs represents
experimental isotopic distributions of the scaled isotopologue intensities. Bar graph (a) shows the
distribution for the homoserine (dark blue) internal standard from the cellobiose dataset and the homoserine
(dark red) internal standard from the lactulose dataset. Bar graph (b) shows the isotopic distribution of
cellobiose (dark blue) and lactulose (dark red). Molecular weights and structures for the compounds are
provided in Table 3-1.
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Figure 3-9. Expanded regions of the mass spectra representing experimental isotopic distributions for
[M-H]- disaccharide ions from two isomers obtained with dual cVSSI employing the Q-Exactive hybrid
quadrupole-orbitrap mass spectrometer. Panel (a) shows mass spectrum of homoserine internal standard
corresponding to the mass spectrum of gentibiose (b). Panel (c) shows the mass spectrum of homoserine
internal standard corresponding to the mass spectrum of melibiose (d). Bar graphs represent experimental
isotopic distributions of the scaled isotopologue intensities. Bar graph (a) shows the distribution for the
homoserine (dark blue) internal standard corresponding to gentibiose and homoserine (dark red) internal
standard corresponding to melibiose. Bar graph (b) shows the isotopic distribution of gentiose (dark blue)
and melibiose (dark red). Molecular weights and structures for the compounds are provided in Table 3-1.
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It is important to point out that not all the linkage isomers were distinguished. This is
demonstrated by the datasets that were obtained for gentibiose and melibiose. These
disaccharides both have (1→6) linkages. gentibiose β (1→6) is a disaccharide composed of two
units of D-glucose and melibiose α (1→6) is a reducing disaccharide formed from the different
monomeric units galactose and glucose (Table 3-1). Figure 3-9b and Figure 3-9d show the
expanded regions of mass spectra displaying isotopic distributions for the disaccharides
gentibiose and melibiose, respectively. The isotopic distributions for the two disaccharides show
the D1 isotopologue being the major peak and the other isotopologues D1, D2, D3, D4 and D5
present in order of decreasing intensities.

Figure 3-9g shows the scaled isotopologue intensities for the triplicate measurements for
gentibiose and melibiose. Figure 3-9f shows the corresponding scaled intensity of the homoserine
internal standard. Both gentibiose and melibiose show similar isotopic distributions (Figure 3-9b
and Figure 3-9d). Total deuterium uptake for both the disaccharides is shown in Table 3-2. The
D2, D3 and D4 isotopologues for gentibiose show slightly increased intensities compared to those
of melibiose. gentibiose has a free anomeric carbon and hence it protonates easily making the
exchangeable hydrogens more acidic. However, these small differences are not significant
enough to distinguish the two-disaccharide isomers

As performed for the monosaccharides, the reproducibility of the disaccharides isotopic
distribution patterns was also examined on different days. Figure 3-10 shows the data collected
for all disaccharide measurements obtained on a later day. Deuterium uptake for all these plots
are provided in Table 3-2. Figure 3-10b and Figure 3-5f provide a comparison of two sets of data
for 1→2 linkage isomers. The isotopologues distributions are consistent within the two sets of
data. However, it is interesting to note that in Figure 3-10a, the corresponding homoserine internal
standard, exhibited less deuterium exposure for sophorose as indicated by the reduced intensities
for the isotopologues D1 and D2.These are reflected by the corresponding reduced intensities for
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the D3, D4 and D5 isotopologues for sophorose (Figure 3-10b). This trend is also very similar
when comparing Figure 3-7e and Figure 3-7f with Figure 3-10c and Figure 3-10d, respectively.
The reduced D2O exposure as revealed by the internal standard for homoserine-turanose is
reflected in the decreased intensities of the D1, D2, D3, D4 and D5 isotopologues (Figure 3-10d).
It is interesting that regardless of these differences in the deuterium uptake of the homoserine,
the isotopic distributions for the disaccharides are very distinct.
The duplicate data for 1→4 linkage isomers (Figure 3-10e and Figure 3-10f) shows
increased exposure for HDX by the internal standard. The increase in the deuterium uptake of
the internal standard results in an increase in the lactulose isotopologues such that the differences
of isotopologues D1, D2, D3, D4 and D5 between cellobiose and lactulose becomes smaller
compared with the data collected on a separate day (Figure 3-8f). However, the isotopic
distributions for the two isomers are still different. Comparing Figure 3-9g and Figure 3-10h for
the 1→6 linkage isomers, it is observed that the isotopic distributions for the two disaccharides
are very similar. In the separate day comparisons, an overall increase in D2O exposure is
observed also as an increase of the isotopologue intensities for D1 and D2 for the internal
standard. This is also observed in the isotopic distributions for the disaccharide (Figure 3-10h). In
these experiments, the isotopologues peaks for both gentibiose and melibiose have relatively
similar intensities. These isomers cannot be distinguished with this setup
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Figure 3-10. Bar graphs presenting scaled isotopic distributions for [M-H]- disaccharide ions for various
isomer species obtained with dual cVSSI employing a Q-Exactive hybrid quadrupole-orbitrap mass
spectrometer. Note these data were collected on a different day than those presented in Figure 3-4 to
Figure 3-8. Bar graph (a) shows the distribution for the homoserine internal standard where (dark blue) and
(dark red) bars correspond to sucrose and sophorose experiments, respectively. Bar graph (b) depicts the
isotopic distributions of sucrose (dark blue) and sophorose (dark red). Bar graph (c) shows the distribution
for the homoserine internal standard where (dark blue) and (dark red) correspond to nigerose and turanose,
respectively. Bar graph (d) shows the isotopic distribution of nigerose (dark blue) and turanose (dark red).
Bar graph (e) shows the distribution for the homoserine internal standard where (dark blue) and (dark red)
correspond to cellobiose and lactulose, respectively. Bar graph (f) shows the isotopic distribution of
cellobiose (dark blue) and lactulose (dark red). Bar graph (g) shows homoserine internal standard (dark
blue) corresponds to gentibiose and (dark red) corresponds to melibiose. Bar graph (h) shows the isotopic
distribution of gentibiose (dark blue) and melibiose (dark red). Molecular weights and structures for the
compounds are provided in Table 3-1

92

3.3.5. Disaccharides-specific HDX Behavior for Different Linkages

When comparing Figure 3-10b to Figure 3-10h, it appears that the isotopic distribution
patterns are different for several linkage isomers studied. For example, the 1→2 linkage isomers
(sucrose and sophorose) may be distinguished from the 1→3 linkage (nigerose and turanose),
1→4 linkage (cellobiose and lactulose) and 1→6 linkage (gentibiose and melibiose) linkage
isomers. Additionally, turanose, a 1→3 linkage isomers may be distinguished from 1→4 and 1→6.
However, nigerose a 1→3 linkage isomer appears to be very difficult to distinguish when
comparing with cellobiose a 1→4 linkage isomer, gentibiose, or melibiose, both 1→6 linkage
isomers. Although visual inspection of Figure 3-10 suggests that such distinctions can be made,
to better determine whether these linkage isomers can be distinguished a more rigorous
mathematical approach was considered namely principal component analysis (PCA)

For details on how the PCA was implemented in detail, see the Experimental section
above. Here the two datasets obtained on different days for each of the disaccharides (Figures
3-5 to 3-10) were used. Figure 3-11 shows the results from the PCA. For this analysis, 60.8% of
the variance is associated with PC1 and 11.30% with PC2. In Figure 3-11, clustering is achieved
for some linkage isomer groups (1→2), (1→3) (1→4), and (1→6). As shown in Figure 3-11, 1→2
linkage isomers (sucrose and sophorose) can be distinguished from 1→3 (turanose), 1→4
(lactulose) and 1→6 (gentibiose and melibiose) linkage isomers. Sucrose, a 1→2 linkage isomer
can be distinguished from turanose (1→3) as well as cellobiose (1→4) linkage isomers..
Admittedly, it was not possible to distinguish some of the linkage isomers. For example, one of
the 1-4(cellobiose) runs clustered with the 1-2(Sophorose) data while the other run was located
near the 1-3(Turanose) cluster. One of the 1-4 (Nigerose) datasets was located alone while the
other clustered with the 1-4(lactulose) data. Finally, there was some overlap between the 14(lactulose) and 1-3(Turanoes) clusters. .
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Figure 3-11. Principal component analysis (PCA) for the disaccharides in Figures 3-5 to 3-10.
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Figure 3-12. Expanded regions of the mass spectra representing experimental isotopic distributions for
[M-H]- trisaccharide ions from two different linkage isomers. Data were obtained in negative ion mode
employing a Q-Exactive hybrid quadrupole-orbitrap mass spectrometer. Panel (a) shows the mass
spectrum of the homoserine internal standard corresponding to the mass spectrum of 2-Fucosylactose (b).
Panel (c) shows the mass spectrum of the homoserine corresponding to the mass spectrum of 3Fucosylactose (d). Bar graphs represent experimental isotopic distributions of the scaled intensity values
for [M-H]- trisaccharide ions for duplicate runs. Bar graph (f) shows the homoserine internal standard (dark
blue) corresponding to 2-Fucosylactose and the homoserine (dark red) internal standard corresponding to
3-Fucosyllactose. Bar graph (g) shows the isotopic distribution of 2-Fucosyllactose (dark blue) and 3Fucosyllactose (dark red). Bar graph (h) and (i) are duplicates of (f) and (g) obtained on a different day to
show reproducibility. Molecular weights and structures for the compounds are provided in Table 3-1
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3.3.6. Glycan-specific HDX Behavior

Rapid HDX as a potential method to distinguish monosaccharides and disaccharides can
also be extended to trisaccharide species such as glycans. In this work, the distinction of linkage
isomers 2’-Fucosyllactose (2’-FL) and 3-fucosyllactose (3-FL) was considered. These are the two
most abundant human milk oligosaccharides (HMOs) present in human breast milk. The two
trisaccharides represented by data in Figure 3-12 are thought to be beneficial for infant health
and development. It has been projected that products containing HMOs will expand in the future;
therefore, there is need for robust analytical methods for the analysis of these compounds[68].
The two isomers are composed of three monomeric units, glucose, galactose and fucose. Both
isomers have a β (1-4) linkage between glucose and galactose. The difference is the bonding
with the fucose monomer. In 2-fucosylactose there is a α(1-2) linkage on the galactose monomer
where as in 3-fucosylactose there is a (α1-3) linkage on the glucose monomer [70] (Table 3-1).

The HDX behavior (Figure 3-12) of these compounds shows two distinct isotopic
distributions for 2’-fucosyllactose and 3-fucosyllactose. The mass spectrum reveals a 7-fold
enhancement in signal intensity for 2-fucosylactose compared with 3-fucosyllactose. The isotopic
distributions obtained from triplicate measurements show that 2-fucosylactose has the most
deuterium uptake with isotopologues D2 being the most abundant. The other isotopologues in
order of decreasing intensities are D1, D3, D0, D4, D5 and D6. 3-Fucosyllactose has a remarkably
distinct isotopic distribution where D0 is the major isotopologue and the other isotopologues are
D1, D2, D3, D4, D5 and D6 in order of decreasing intensity.

Figure 3-12i and Figure 3-12h show isotopic distributions from triplicate measurements
obtained on a different day for the trisaccharide glycans and the corresponding homoserine
internal standard, respectively. The isotopic distributions (Figure 3-12i) are very similar to those
obtained in Figure 3-12g. However, the deuterium uptake for both 2-fucosylactose and 396

fucosylactose is relatively higher. This also corresponds to a relatively high deuterium uptake by
the internal standard (Figure 3-12h) on that day. It is interesting to note that Figure 3-12h shows
more deuterium uptake for the 3-fucosylactose-homoserine (isotopologues D1 and D2). This is
reflected in the isotopic distributions of 3-fucosylactose (Figure 3-12i), which also shows a much
higher deuterium uptake. Thus, the relative differences in intensities for isotopologues D1, D2,
D3, D4, D5 and D6 between the two isomers is smaller in Figure 3-12i compared with Figure 312g. Conversely, isotopologue D0 shows a large difference indicating the presence of more
deuterium exposure by the 2-fucosylactose isomer. The corresponding deuterium uptake for
these later experiments is provided in Table 3-2.

3.3.6 Single Spray cVSSI Experiments

To demonstrate the importance of the droplet mixing via the dual cVSSI setup, single
emitter cVSSI experiments were conducted. A solution of the analyte prepared in H2O:D2O
solvent with the same concentrations as those utilized in dual cVSSI experiments. Immediately
after preparation, the samples were sprayed into the inlet of the mass spectrometer using a single
cVSSI device. A flow rate of 5 μl/min and a negative bias potential of 2 kV was applied. The
resulting experimental isotopic distribution of the scaled intensity values for the four pairs of
disaccharides is shown in Figure 3-13. Bar graph 3-13a presents (1→2) linkage isomer (sucrose
and sophorose) data. The isotopic distributions are very different from those obtained with the online HDX droplet mixing. The major isotopologues in Figure 3-13a are the D3 followed by the D4,
D5, D2, D6. D1, D7 and D0 features in order of decreasing intensity. Although there may be slight
differences in some isotopologues, overall, the isotopic distributions in Figure 3-13a are
indistinguishable indicating the necessity to perform in-droplet HDX.
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Figure 3-13. Bar graphs representing experimental isotopic distributions of the scaled isotopologue
intensity values for [M-H]- disaccharide ions from four pairs of linkage isomers. Data were obtained with
online single-emitter cVSSI with an LTQ linear ion trap mass spectrometer. Bar graph (a) shows 1→2
linkage sucrose (dark blue) and sophorose (dark red). Bar graph (b) shows 1→3 linkage nigerose (dark
blue) and turanose (dark red). Bar graph (c) shows 1→4 linkage cellobiose (dark blue) and lactulose (dark
red). Bar graph (d) shows 1→6 linkage gentibiose (dark blue) and melibiose (dark red). Molecular weights
and structures for the compounds are provided in Table 3-1

The remaining linkage groups show very similar isotopic distributions. Bar graph 3-13b
shows the isotopic distribution for the 1→3 linkage nigerose and turanose. The order of increasing
intensities for the isotopologues is very similar with the isotopologues for the (1→2) linkage data.
This shows that the reaction that involves dissolving the disaccharide within H2O:D2O mixtures
for short times cannot be used to distinguish isomers with different linkages. Bar graph 3-13c
shows the isotopic distribution of 1→2 linkage cellobiose and lactulose while bar graph 3-13d
shows the isotopic distribution of 1→2 linkage gentibiose and melibiose. Both 1→2 and 1→3 linkage
show similar isotopic distributions similar to those obtained for 1→4 and 1→6 linkages. The
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intensities of the isotopologues are not significantly different among these isomers to be able to
distinguish them.

3.4. Conclusion
The experiments presented above show an alternative measurement method for
potentially distinguishing compound isomers using solution-phase HDX. Experiments were
conducted for three pairs of monosaccharide isomers, four pairs of disaccharide isomers, as well
as one pair of glycan isomers. A new ionization method, dual-capillary vibrating sharp-edge spray
ionization (cVSSI) was employed to provide efficient droplet mixing for analyte and D2O reagent
droplets. The technique utilizes a relatively limited deuterating reagent and experiments could be
conducted from aqueous environments. The latter feature is attractive as it offers advantages for
native MS experiments.

In summary, several isomers with the same linkage or different linkages were
distinguished based on unique isotopic distributions arising from HDX. The technique can also be
applied to oligosaccharides as shown by the differentiation of the two glycan isomers. The isotopic
distributions obtained are very reproducible and are not affected by ambient conditions indicating
that cVSSI achieves rapid quenching of HDX reactions. However, it is important to note that the
cVSSI platform is open to the environment.

Therefore, mixing efficiencies, changes in

atmospheric humidity as well as small differences in pulled-tip diameter could give rise to
decreased reproducibility. These factors offer the opportunity to build upon the work here to obtain
even higher resolving isotopic distributions. Particularly encouraging is that the patterns of the
isotopic distributions for the disaccharides on different days are relatively reproducible. Although
this work does not present real world sample analysis, it contributes to the series of work that has
been presented previously for alternative methods for metabolomics analysis
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4. Combining Field-enabled capillary Vibrating Sharp-Edge Spray Ionization
with Microflow Liquid Chromatography and Mass Spectrometry to Enhance
‘Omics Analyses.
Reprinted in part with permission from Journal of The American Society for Mass Spectrometry:
Combining Field-enabled capillary Vibrating Sharp-Edge Spray Ionization with Microflow Liquid
Chromatography and Mass Spectrometry to Enhance ‘Omics Analyses. Sandra N. Majuta, Anthony
DeBastiani, Peng Li, * Stephen J. Valentine. : J. Am. Soc. Mass Spectrom. 2021, 32, 473−485

4.1. Introduction
Mass spectrometry (MS)-based proteomics and metabolomics platforms have advanced
significantly over the last 20 years. Much of the development work has focused on MS
instrumentation and techniques [1-11]. Additionally, developments in liquid chromatography (LC)
have enabled complex mixture analysis [12-26]. This has led to the wide-scale adoption of LCMS techniques by the scientific community for the study of human disease. Indeed, LC-MS ‘omics
methods have been broadly utilized to investigate conditions such as cardiovascular disease [2732], cancer [33-39], diabetes [28,40-45] ,and neurodegenerative disorders [46-49].
Despite wide-scale adoption of LC-MS techniques for ‘omics analyses, often the sample
complexity presents limitations in the comparisons of different biological samples. A primary
concern is the inability to detect and quantitate low-signal species whose analytical signals are
often masked by coeluting higher-signal ions. One frequently employed approach for enhancing
the characterization of low-signal species is nanoflow LC [26, 50-60]. The low-flow characteristics
of this

approach permit the use of nanoelectrospray ionization [61] (nESI) to boost the overall

ionization efficiencies of mixture components. As an example of such signal increases, consider
the remarkable sensitivity advantages recently reported for LCnESI-MS experiments for
metabolite characterization using limited numbers of cells [62]. Although the sensitivity of the
mass spectral measurement is enhanced by nESI, the low flow rates used to achieve the
ionization improvements introduce problems for comparative ‘omics investigations. Recently,
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Kuster and co-workers succinctly summarized these problems as being associated with
reproducibility (e.g., column manufacture, spray stability, column overloading) and problem is
encountered for negative ion mode analyses in that nESI is hampered by an accompanying
corona discharge[64.65] which often requires auxiliary methods for improved performance [66].
Because of the throughput and stability issues associated with nanoflow LC separations,
some researchers have advanced the use of microflow LC separations for ‘omics studies [63, 6769]. Increasingly groundbreaking methods have been developed for high-sensitivity ‘omics
analyses of complex biological samples which operate in this flow regime [70-72]. For these
separations, the higher flow rate requires the use of a heated nebulizer gas to ensure efficient
droplet (and thus ion) production in the ESI source. Here, a trade-off in sensitivity for robustness
is apparent when compared to nanoflow LC-MS experiments.
In 2018, Li and co-workers developed a new technology for efficient sample nebulization
and ionization of analyte molecules. The new approach, termed vibrating sharp-edge spray
ionization (VSSI), uses mechanical vibration to produce droplet streaming from a sharp surface
[73]. Shortly later, it was shown that precut fused silica could serve as the vibrating substrate
(cVSSI), and samples could be infused at rates commensurate with LC separations [74];
remarkably, a single device was shown to efficiently nebulize LC effluent of flow rates ranging
from 1 to 500 μL·min−1. As with VSSI, for cVSSI, the importance of the “sharp edge” is also
evident; it has been determined that the most efficient fused-silica tips are those having jagged
rather than smooth cuts. Presumably, this produces a more expansive area from which solvent
streaming may occur. Notably, the employment of the sharp edges in VSSI and cVSSI is what
allows for such high efficiency nebulization with very little power requirements (see below) [7376].
The proof-of-principle experiments mentioned above presented cVSSI as a new member
of an increasing repertoire of techniques seeking to provide sample nebulization without the use
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of a heated gas. Other strategies include those based on ultrasound atomization to generate
aerosols such as an array of micro machined ultrasonic electrospray (AMUSE) [77], ultrasonically
assisted electrospray [78], single-pulse nanoelectrospray [79], and surface acoustic wave
nebulization (SAWN)[80] Notably, some like SAWN have also been coupled with LC, but no
advantages over gas nebulization with ESI have been presented [81]. Compared to other
mechanical-based methods, VSSI does not require establishing a well-defined acoustic wave field
onto the bulk solvent followed by droplet detachment to generate liquid droplets. Rather, droplets
are produced directly by the streaming of solvent from a vibrating sharp edge. The unique manner
in which nebulization is achieved by VSSI allows one to utilize a wide range of emitters (sharp
edge and emitter tip types and diameters) that are optimized for their ionization performance
without requiring any variation in the acoustic wave field. Additionally, VSSI is highly energy
efficient, with a power consumption of 100−500 mW depending on the emitter and flow rates. The
high efficiency ensures the robust operation of VSSI, which is critical for LCMS experiments.
Recently, field-enabled cVSSI was investigated as a means for enhancing the ionization
of macromolecules from aqueous solutions [82]. Notably, for negative ion mode analyses, the
ionization of large biomolecules was observed to increase by ∼10−100-fold with this combination
when compared to state of-the-art ESI approaches. Additionally, smaller yet significant increases
were also demonstrated for positive ion mode analysis. The fact that such increases in ionization
efficiency were obtained using direct infusion employing microflow rates prompted these
investigations of field-enabled cVSSI for LCcVSSI-MS analyses.
The combination of field-enabled cVSSI with LC-MS is evaluated here for its performance
in metabolomics analyses in both positive and negative ion mode. Overall, compound ionization
is enhanced for field-enabled cVSSI compared to gas nebulization ESI by factors of 2−5 across
the metabolomics samples investigated here. Previous comparisons of voltage-free cVSSI and
ESI found that the former underperformed the latter in compound ionization by ∼10-fold. Thus, it
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can be argued that the ionization improvement from the addition of voltage to cVSSI represents
a 20−50-fold gain in ionization efficiency compared with voltage-free cVSSI [74]. This work is
similar to powerful demonstrations of solvent-assisted ionization inlet (SAII) [83] as an enhanced
ionization method for LC-MS investigations [84, 85], the results described below indicate that,
even at this early stage of development, cVSSI is another significant tool for enhancing
comparative ‘omics analyses. Of note is the fact that more than 2 decades ago, Fenn and
coworkers demonstrated ultrasonic nebulization coupled with ESI for low μL·min−1 flow rates as
existing ESI sources alone were not efficient for such conditions [86]. This interface was
supplemented by superior gas-assisted nebulization in the ensuing decades. As the work below
demonstrates an improvement over the gas-assisted nebulization approach, a return to vibrationassisted techniques may be a fruitful endeavor in the future.

4.2. Experimental
4.2.1. Chemicals and Solvents
Metabolite standards-arginine caffeine, acetaminophen, dopamine, and aspartame-were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Glycan, 6-sialyllactose (sodium salt), at ≥90
% purity was purchased from Cayman Chemicals (Ann Arbor, MI). The nucleotides-cytidine 5′triphosphate disodium salt, ≥95% CTP, 2′- deoxycytidine 5′-triphosphate disodium salt, ≥95%
dCTPNa2, adenosine 5′-triphosphate (ATP) disodium salt hydrate ATP, thymidine 5′-triphosphate
sodium salt, ≥96% TTP, dTTP, and 2′-deoxyadenosine 5′-triphosphate disodium salt, ≥97%
dATP-Na2-were purchased from Sigma-Aldrich (St. Louis, MO, USA). Optima LC/MS grade
water, Optima LC/MS grade acetonitrile, and Invitrogen ultrapure DNase/RNase-free distilled
water were purchased from Fisher Chemical (Fair Lawn, NJ, USA). Ion pairing reagents
1,1,1,3,3,3-hexafluoro-2- propanol (HFIP), triethylamine HPLC grade solvent (TEA), and formic
acid were obtained from Sigma-Aldrich (St. Louis, MO, USA) and Thermo Fisher Scientific
(Waltham, MA, USA), respectively. Ammonium bicarbonate (Reagent Plus, ≥99.0%) and urea
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were purchased from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were used without further
purification. Tables 4.1 and 4.2 show the structures of all molecules used for the nucleotide and
metabolite standard mixtures, respectively, used in these experiments
.

4.2.2. Sample Preparation
For the metabolomics experiments, the following mixtures were prepared as follows. For
the metabolite standard solution, compounds were mixed together to a final concentration of 0.2
mg/ml−1 for each standard in optima LC/MS grade water. For the nucleotide mixture used in
negative ion mode studies, individual nucleotides were also mixed together to a final
concentration of 0.2 mg/ml−1 in ultrapure DNase/RNase-free water. Additionally, ion-pairing
reagents were added to the nucleotide mixture to bring the final concentration to 8.6 mM TEA and
100 mM HFIP.
For experiments in which conditions periodically alternated between application of fieldenabled cVSSI and ESI, five separate solutions were employed. The solution was of cytidine
triphosphate in 100 mM HFIP and 8.6 mM TEA in water (final pH of 8.3 ± 0.1) at a concentration
of 0.5 mg/ml−1.

4.2.3. LC and PDA Analysis Setting
A Thermo Scientific Q Exactive mass spectrometer with an Accela ultra-performance
liquid chromatography (UHPLC) and Accela photodiode array detector (PDA) (Thermo Fisher,
San Jose, CA) were used for the separation and acquisition of absorbance measurements across
multiple wavelengths, respectively. Twenty microliters of sample was injected on to a 10 cm long
reversed-phase (C18) analytical column (PerkinElmer, Waltham, MA) for LC separation of
metabolites and nucleotides. The auto sampler temperature was set at 4 °C, and the flow rate
used for all separations was 1000 μL·min−1. The solvent was split to reduce the load to the cVSSI
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device using a t-connector (see LC-cVSSI section) in a 30:970 μL· min−1 ratio; here, 3% of the
eluent is channeled to the cVSSI source for mass analysis. The post-column split was achieved
using the appropriate lengths of fused-silica capillary (360 μm o.d. × 100 μm i.d.) attached to a
microcross tee (Figure 4.1). This same split was used for all experiments performed using the
commercial heated electrospray ionization (HESI) source.

Liquid chromatography

cVSSI

Piezoelectric transducer

Amplifier

A

B

HPLC pump

glass slide

Waveform generator

LC buffers

MS

droplets
multiport valve
t-connector

plastic tubing

C18 column
fused silica capillary

PDA detector

waste

LC tubing

fused silica
capillary

nichrome
wire

pulled glass capillary

High voltage

Figure 4-1. Schematic diagram of the LC-cVSSI set up for the separation and identification of metabolites,
nucleotide triphosphates, and myoglobin digest peptides. Component parts are labeled. Headings indicate
hyphenated instrument parts

For the separation of the metabolite standard components in positive ion mode, a buffer
system consisting of 0.1% formic acid in water (buffer A) and 0.1% formic acid in acetonitrile
(buffer B) was used as the aqueous and organic phases, respectively. Gradient elution was
performed for the separation of mixture components using the buffer compositions described
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previously [74]. Briefly, compound elution was achieved using an 18 min separation where the
buffer gradient was as follows: 0 min 5.0% B; 1.5 min 5.0% B; 8.5 min 30% B; 11.5 min 100% B;
14.5 min 100% B; 17.5 min 5% B, and 18 min 5% B. Channels A, B, and C of the PDA detector
were set at 270, 214, and 205 nm, respectively, and the UV chromatogram was monitored to
ensure LC separation reproducibility. UV chromatograms for all separations are provide in the
(Figure 4-2a and b).
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Figure 4-2. Ultra-Performance Liquid Chromatography-Photodiode Array Detector (UHPLC-PDA) XICs
for positive metabolites obtained from experiments using the HESI source (a) and the field-enabled cVSSI
source (b). Labeled peaks correspond to the compounds listed in Table 4-1. Also shown are the UV
chromatograms for the nucleotides mixture obtained from experiments using the HESI source (c) and the
cVSSI source (d). Labeled peaks correspond to the compounds listed in Table 4-2. UHPLC-PDA
chromatograms were obtained in the UV/Vis range of 200–600 nm.
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For the separation of the nucleotides in negative ion mode, a reversed-phase LC method
was adapted from one reported previously for the separation of these compounds [87]. The mobile
phase composition and gradient were slightly optimized as described below to achieve high
efficiency separations for nucleotides and peptides. Here, buffer A consists of 100 mM HFIP and
8.6 mM TEA in water (final pH of 8.3 ± 0.1), and buffer B consists of 20% water and 80%
acetonitrile. The buffer system gradient employed was as follows: 0 min 0% B; 10 min 0% B;
10.10 min 20% B; 15.0 min 20% B; 15.10 min 100% B; 22.00 min 100% B; 24.00 min 100% B,
and 34.00 min 0% B. Overall, when compared with the original method, buffer B contained
significantly more organic content and the elution end point was extended to 100% B to ensure
that all molecules were eluted from the column prior to subsequent runs. For the PDA detector,
channels A, B, and C were set at wavelengths 254, 270, and 205 nm, respectively. UV
chromatograms for all separations are provide in the (Figure 4-2c and d).

4.2.4. Construction and Operation of the cVSSI Device
A detailed description of the cVSSI device has been provided elsewhere[73,74]. Briefly,
the cVSSI device was constructed by attaching a piezoelectric transducer (7BB-27-4 L0, Murata
diameter = 27 mm) to one end of a no. 1 glass slide coverslip (w × l = 25 × 60 mm) (VWR, Radnor,
PA, USA) using epoxy glue. A glass capillary emitter, approximately 5 cm in length (500 μm o.d.
× 360 μm i.d.), which has been pulled (Sutter Instrument Company, Novato, CA) to a final tip
diameter of approximately 25 μm, was attached to the cover slide. The emitter tip diameter was
subsequently enlarged (∼100 μm) with a mechanical cut using a ceramic cutter; this was required
to ensure the correct post-split flow (see discussion below). Blunt, fused-silica capillary (360-μm
o.d. × 100-μm i.d.) pieces (∼3 cm long) were glued to the flat end of the emitter tip. Thin-walled
PTFE tubing was used to connect (slip fit) the LC eluent (from the post-column split) and the
cVSSI device fused-silica capillaries (360-μm o.d.). A 5 cm long piece of nichrome wire was glued
into the thin-walled PTFE tubing to provide a point of voltage application for field-enabled cVSSI
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experiments. Finally, The RF signal (∼95 kHz square wave) applied to the piezoelectric devices
was generated using a function generator (AFG-1062, Tektronix, Beaverton, OR, USA) connected
with an amplifier (Krohn-Hite 7500, Brockton, MA, USA) (Figure 4-1). Notably, sample
nebulization is achieved only over a very narrow frequency range (±1 kHz). Additionally, previous
measurements of droplet diameters (aqueous) produced by tips with similar internal diameters
show a size distribution centered at ∼15−25 μm, which is independent of operational frequency
[75].
The pulled glass tip is glued to the microscope slide typically at a 45−75° angle relative to
the distal edge of the slide (Figure 4-1). Iterative testing revealed that such an arrangement
provides the most robust nebulization. Although not fully confirmed, it is possible that the diagonal
arrangement ensures that the glass capillary encounters an antinode region(s) at the edge of the
bulk glass material (slide), thus ensuring maximal vibration. Additionally, such an angle provides
clearance that is sufficient for coupling the PTFE tubing such that it does not affect the vibration
of the glass slide. For these experiments, all device parameters (e.g., emitter tip angle and length)
were maintained as precisely as possible in order to provide reproducible droplet size
distributions; typically, cVSSI nebulization of aqueous sample using similar flow rates produces
average droplet sizes of ∼15 to ∼25 μm.74,75

4.2.5. Mass Spectrometer Settings
A Q-Exactive hybrid quadruple Orbitrap mass spectrometer (Thermo Fisher, San Jose,
CA) was utilized for all LC-MS measurements. The instrument features high-performance
quadrupole precursor ion selection with high resolution, accurate-mass (HR/AM) Orbitrap
detection. Instrument conditions for the tune file were optimized in both positive and negative ion
mode using the auto defaults in the XCalibur software for a flow rate of 30 μL·min−1.
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For metabolite standard analysis, experiments were conducted in positive ion mode using
a mass-to-charge (m/z) scan range of 150−1000 (1 microscan). The resolving power was set at
70,000 for all full MS scans. The AGC target was set at 1 × 106 , and the inlet capillary temperature
was maintained at 250 °C. The sheath gas flow rate was set at 23, the auxiliary gas flow was set
at 8, and the sweep gas flow rate was set at 1. The S-lens RF level was set at 50 V, and the aux
gas heater temperature was 125 °C. The applied voltage for the HESI source was +3.5 kV.
The nucleotide mixture analysis was conducted in negative ion mode. The parameters
used were a m/z scan range of 350−1000 (1 microscan), a resolution of 70,000, an AGC value of
5 × 105 , a maximum injection time of 100 μs, a sheath gas flow rate of 23, an auxiliary gas flow
rate of 8, a capillary temperature of 250 °C, a S-lens RF level of 50 V, and auxiliary gas heater
temperature of 125 °C. The applied voltage for the HESI source was −2.5 kV.
The respective tune files for metabolites and nucleotides were used for the cVSSI
experiments with the exception that the sheath gas, auxiliary gas, and sweep gas flow rates were
all set to zero. Additionally, different applied voltages were used; +2.0 and −2.0 kV were used for
positive and negative ion mode analyses, respectively. Ion production for the cVSSI experiments
was achieved by placing the cVSSI device ∼1 cm from the inlet of the mass spectrometer.
Samples were analyzed in duplicate for each of the LC-MS runs to provide comparisons of
average intensities.
For alternating field-enabled cVSSI and ESI experiments, an LTQ-XL mass spectrometer
was utilized. For positive and negative ion mode experiments, DC biases of +2.0 and −2.0 kV,
respectively, were used to mimic the voltages employed in the LC separations for field-enabled
cVSSI. Additionally, the same emitter tip distance (∼1 cm) was used to ensure a similar electric
field. During data collection, the signal from the waveform generator was turned on and off at
specified times. The DC bias utilized for the HESI source was selected by the data acquisition
software to provide optimal performance for the given flow rate with the selected polarity. For the
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cVSSI, single experiments were performed in which the ion signal levels of single component
(nucleotide) samples were maximized at the selected flow rates for the given polarity and emitter
tip distance used.

4.2.6. Dataset Feature Identification and Abundance Comparisons
Dataset features were identified using exact mass comparisons for retention time (tR)resolved mass spectra. Tentative assignments were made based on a ≤10 ppm mass match.
Extracted ion chromatograms (XICs) were obtained using the XCalibur software suite. Here, the
monoisotopic mass for each matched peak was employed to extract the ion chromatogram by
summing the intensities for each m/z value in a 0.02 window centered on the peak apex across
the tR range. Peak abundances for each XIC were obtained using the XCalibur software suite
where peak integration was employed using the 5% peak height limits. Peak abundances and
peak widths for all identified compounds are reported in Tables 4-1 and 4-2. For comparison
purposes, tR alignment was performed for the cVSSI and ESI datasets by plotting the tR values
of the former dataset as a function of the values for the latter.

4.3. Results and Discussions
4.3.1. Ion Abundance Comparison in Negative Ion Mode
Figure 4-3 shows XIC features from the tR-aligned datasets for LC-MS analyses of the
nucleotide mixture. Here, the ion abundance advantage of field-enabled cVSSI over ESI is
apparent. Peak intensity increases of ∼2−6-fold are observed for the components of this mixture.
Inspection of Figure 4-3 suggests that peak height may not be the best indicator of the
enhancement in compound ionization afforded by the cVSSI approach. This results from the
broader nature of the peaks that are obtained from the cVSSI dataset. Indeed, from Table 4-1,
the average increase in peak width for the nucleotide mixture is ∼1.07 ± 0.04-fold. In the
discussion of these data and that to follow, it is useful to consider the difference in terms of the
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number of theoretical plates (N). N can be estimated using the tR values from the XICs as well
as the peak widths (W) according to eq 1:
𝑡

2

𝑁 = 16 (𝑊𝑅)

(1)

The dataset features for ATP (Figure 4-3) provide N values of 31 and 39 for the cVSSI and ESI
experiments, respectively. Although this disparity in peak width is small, larger differences are
observed for other datasets (see below). Overall, peak area better represents the complete
ionization of an equal amount of a particular compound. For the nucleotide mixture, on average,
the signal enhancement by cVSSI is observed to be 4-± 2-fold.
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Figure 4-3. Expanded regions of XICs (LC-MS) for components in the nucleotides mixture (see
Experimental section). Dotted and solid lines represent LC-ESI-MS and LC-cVSSI-MS data, respectively.
Peaks represent the following compounds: 6-Sialyllactose (a), CTP (b), ATP(c) and, TTP (d). Molecular
masses and structures for the compounds in the mixture are provided in Table 4-1
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Table 4-1 Nucleotide triphosphates analyzed in negative mode

a Common

names, abbreviation, molecular formulae and molecular mass of the nucleotides
representations of the nucleotides drawn using the chem drawer software suite
c Integrated peak area using tools in X-calibur software from the XICs of each nucleotide with the
HESI source. Values in parenthesis is the difference in intensity between two runs.
d Integrated peak area using tools in X-calibur software from the XICs of each nucleotide with the
cVSSI source. Values in parenthesis is the difference in intensity between two runs.
e Ratio (cVSSI: HESI) of the integrated peak area of the XICs of each nucleotide
fPeak width obtained with the HESI source in minutes
gPeak width obtained with the cVSSI source in minutes
b Structural
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For many MS instruments, the detection of larger ion signal levels is associated with
increased noise levels. Therefore, it is instructive to consider whether or not the peak area
enhancements are not as important in light of noise considerations. For this comparison, the ion
intensities of 6- sialyllactose and dTTP were compared between separate LCcVSSI-MS and LCESI-MS experiments. The mass spectra obtained by signal averaging across the peak widths
(FWHM) for these compounds are shown in (Figure 4-4) in the Supporting Information. Overall,
the peak heights are reflective of the ion intensity enhancements as reported by the XIC peak
areas. Additionally, by zooming the intensity range by several orders of magnitude (Figure 4-4),
it is clear that no increase in noise is recorded for the cVSSI experiments. Therefore, the signal
gain can be argued to be significant especially as it relates to ‘omics experiments where ion
utilization for tandem MS experiments is especially important.
Although the ion abundance enhancements are substantial, this single experimental type
does not indicate the wider utility of field-enabled cVSSI for microflow LC-MS analyses. For
example, the nucleotide mixture components all eluted during the isocratic portion of the LC buffer
profile (see Experimental Section).Admittedly, this enhancement is somewhat to be expected as
previous work showed that field-enabled cVSSI could provide significant (≥10-fold) ionization
improvements for large biomolecules in aqueous samples [82]. Primarily this advantage was
attributed to an ability to suppress the corona discharge for field-enabled cVSSI in negative ion
mode [64, 88-91]. Because of this problem, gas nebulization is often required for negative ion
mode analysis of such samples, which can be suggested to disrupt high efficiency transfer of
droplets into the mass spectrometer. Notably, limited positive ion mode experiments conducted
at the same time as the negative ion mode studies suggested that cVSSI may also provide
enhancements in sample nebulization compared with gas determine whether or not ionization
enhancement is observed for negatively charged biomolecules eluting from a reversed phase
column in solvent mixtures of higher organic content.
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Figure 4-4. Signal averaged (FWHM of the ion chronogram) mass spectra recorded for 6- sialyllactose
(A-D) and dTTP (E-H). Panels A (full-scale intensity) and B (zoomed intensity scale) show the mass
spectrum obtained for 6-sialylactose using field-enabled cVSSI. Panels C (full-scale intensity) and D
(zoomed intensity scale) show the mass spectrum obtained for 6- sialyllactose using ESI. Panels E (fullscale intensity) and F (zoomed intensity scale) show the mass spectrum obtained for dTTP using fieldenabled (-2 kV) cVSSI. Panels G (full-scale intensity) and H (zoomed intensity scale) show the mass
spectrum obtained for dTTP using HESI.
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4.3.2. Metabolite Standard Mixture Analysis in Positive Ion Mode.
The standard compounds used in the metabolite mixture here are the same as those used
in a previous LC-MS study employing field-free cVSSI [74]. The previous work showed that fieldfree cVSSI could effectively nebulize LC eluent in the microflow regime as well as effectively
produce ions even without the aid of an applied voltage. In head-to-head comparisons with ESI,
the field-free cVSSI was not observed to be as efficient (by ∼10-fold) at ionizing compounds
across the tR range. Therefore, to some degree, the comparisons presented here present the
rapid development of cVSSI technology over the last 2 years.
The increase in the ionization of the standard compounds is revealed by the XICs in Figure
4-5. Here, the ionization advantage is very similar to that observed for the digest peptides in
positive ion mode. That is, peak heights are increased by factors of ∼2 to 3 across the tR range
for the field enabled cVSSI experiments. As with the digest peptides in positive ion mode, the
peak widths are observed to be slightly wider (1.1 ± 0.1) for the cVSSI datasets (Table 4-2). For
comparison, the dataset features corresponding to aspartame provide N values of 9.6 × 10 2 and
1.1 × 103 for the cVSSI and ESI experiments, respectively. When the ionization enhancement is
obtained from peak area comparisons, only a slight increase is observed (4 ± 2-fold on average)
compared with that suggested by peak height comparison.
It is instructive to compare these findings with those obtained for the previous work that
evaluated voltage-free cVSSI for LC-MS experiments [74]. The voltage-free study was carried out
using a similar post-split flow rate (50 μL·min−1). When compared with ESI, the ionization
efficiency of field-free cVSSI was reported to be ∼10-fold lower than that of ESI. So, multiplying
this by the improvement factor reported above for field-enabled cVSSI provides ∼40-fold
improvement in ionization efficiency over the previous work for these small molecules in positive
ion mode.
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Figure 4-5 Expanded regions of XICs (LC-MS) for components in the metabolite standard mixture (see
Experimental section). Dotted and solid lines represent LC-ESI-MS and LC-cVSSI-MS data, respectively.
Peaks represent the following compounds: arginine (a), dopamine (b), acetaminophen (c), caffeine (d) and
aspartame (e). Molecular masses and structures are provided in Table 4-1.
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Table 4-2. Metabolites identified in positive mode

a Common

names, abbreviation, molecular formulae and molecular mass of the metabolites
representations of the nucleotides drawn using the chem drawer software suite
c Integrated peak area using tools in X-calibur software from the XICs of each metabolite with the
HESI source. Values in parenthesis is the difference in intensity between two runs
d Integrated peak area using tools in X-calibur software from the XICs of each metabolite with the
cVSSI source. Values in parenthesis is the difference in intensity between two runs.
e Ratio (cVSSI: HESI) of the integrated peak area of the XICs of each metabolite
f Peak width obtained with the HESI source in minutes
g Peak width obtained with the cVSSI source in minutes
b Structural
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4.3.3. Electric Field Effects
One question that arises is whether or not the observed increase in ion signal levels results
primarily from the application of a DC voltage to a sharp emitter tip. That is, would the same signal
levels be achieved in the absence of substrate vibration? To examine the effect of emitter tip
vibration, experiments were conducted in which the piezoelectric transducer was periodically
activated for samples infused through a biased pulled-tip emitter. Three on/off periods were
conducted for solutions mimicking analytes under their elution conditions. Figure 4-6 shows the
ion chronogram obtained upon analyzing a solution containing cytodine triphosphate in negative
ion mode. The chronogram shows that the signal level during the vibration-active periods ranges
from ∼0.9 to 1.1 × 108. There is essentially no signal during the vibration-off periods, and a large
solvent droplet grows at the emitter tip as the field is not sufficient to induce Taylor cone formation
for these high flow rates (∼30 μL·min−1 ).
For the Nt17 peptide analyzed from the aqueous solution (Figure 4-7), the ion signal levels
are ∼4 to 7 × 106 , on average, during the vibration activation periods. As with the nucleotide,
virtually no ion signal is observed during the vibration-off period, indicating that the field is still
insufficient to produce ions. Notably, when an activated transducer on a microscope slide is
placed directly above a detached emitter with an applied DC voltage, no ions are produced. This
indicates that no coupling of fields from transducer activation and the DC bias is responsible for
ion production. Additionally, if the applied voltage frequency falls outside the narrow operational
range of the cVSSI device, no ions are produced.
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c

Figure 4-6. (a) Ion chronogram obtained upon infusing a sample solution of cytidine triphosphate through
a biased (-2 kV) cVSSI device during the cycling on and off the waveform required to drive the piezoelectric
device. One “on” and one “off” cycle are labeled. (b) A typical mass spectrum obtained upon emitter tip
vibration (on cycle). The observed ions are labeled. (c) A typical mass spectrum obtained upon stopping
emitter tip vibration (off cycle).
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Figure 4-7. (a) Ion chronogram obtained upon infusing a sample solution of Nt17 peptide (see text for
details) through a biased (-2 kV) cVSSI device during the cycling on and off the waveform required to drive
the piezoelectric device. One “on” and one “off” cycle are labeled. (b) A typical mass spectrum obtained
upon emitter tip vibration (on cycle). The observed ions are labeled. (c) A typical mass spectrum obtained
upon stopping emitter tip vibration (off cycle).
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4.3.4. Ionization Mechanism Considerations.
It is instructive to compare the relative ion intensities for the field-enabled cVSSI and ESI results.
That is, do the compounds exhibit the same ordering of ion intensities for the different ionization
sources? Figure 4-8 shows the relative ion intensities for the standard metabolites examined in
negative ion mode. The results from the duplicate analyses show very different relative ion
intensities. For example, the dTTP ions observed in the LC-MS analyses employing field-enabled
cVSSI show the greatest ion intensities. In contrast, these ions exhibit some of the lowest ion
signal levels in the ESI experiments. Additionally, for the ESI experiments, all compounds eluting
at a retention time that is delayed relative to that of 6-sialyllactose exhibit ion intensities of lower
levels (Figure 4-8). For the cVSSI experiments, three of these five compounds actually have ion
signal levels higher than those for 6-sialyllactose; the other two have signal levels that are closer
to that observed for 6- sialyllactose when compared to ESI experiments. Because these ions elute
under isocratic conditions, a question arises as to whether or not such observations can be used
to better understand differences in ionization processes.
In a previous study, the relative ionization efficiencies of a number of amino compounds
were compared for experiments employing voltage-free cVSSI, field-enabled cVSSI, and ESI [75].
The studies also compared results for aqueous and methanol samples. Multiple regression
analysis suggested ionization efficiency correlated most often with the log of the base dissociation
constant (pKb). One exception was observed for field-enabled cVSSI of aqueous samples. Here,
the strongest correlating compound feature was the log of the partition coefficient (log P) and pKb
was not observed to correlate with ionization efficiency. The data described above are somewhat
consistent with the results from the previous study as, here, the majority of the more nonpolar
compounds have ion signal levels greater than that of 6-sialyllactose for the cVSSI experiments.
In contrast, all of the more nonpolar compounds have lower ion signal levels for ESI.
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Figure 4-8. Bar graph showing the ion abundance ratios for the metabolomics standards analyzed in
negative ion mode. Ratios were obtained by dividing the peak areas for each ion (Table S1) by the peak
area for 6-sialyllactose. Results for ESI and field-enabled cVSSI are represented by the blue and red
bars, respectively. The error bars represent the difference between the ratios obtained from the duplicate
LC-MS runs.

The other LC-MS experiments reported here utilized gradient elution, and so it is not
possible to consider the ion signal levels in light of the previous study, which correlated different
physicochemical parameters. That said, there are still notable differences in relative ion signal
levels between the field-enabled cVSSI and ESI experiments. For example, for the cVSSI
experiments of the metabolite standards analyzed in positive ion mode, the ion intensities are
ordered as aspartame > caffeine > arginine > acetaminophen > dopamine. In comparison, the
ordering for the ESI experiments are caffeine > aspartame > acetaminophen > arginine >
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dopamine. Although beyond the scope of the work reported here, studies which examine
compound properties and device parameters that lead to such differences in ion signal levels are
very important as they could lead to the development of ionization sources, providing even greater
gains in ion production across this important flow regime.

4.3.4. Peak Broadening in Field-enabled cVSSI Experiments
Peak Broadening in Field-Enabled cVSSI Experiments. The purpose of these proof-ofprinciple experiments described here is to determine the ionization enhancements afforded by
the current embodiment of field-enabled cVSSI for LC-MS experiments. However, it is observed
that the LC peak widths are slightly broader for all cVSSI experiments. Indeed, the features in the
XICs are 7 ± 4, and 10 ± 10% wider for the analytes in Tables 4-1 and Table 4-2, respectively.
This slight peak broadening is likely attributable to slightly longer post-split residence times .From
an examination of the analyte transit times after the PDA detector, it was observed that the
residence times of the analytes were ∼2.3× longer. This suggested that over time it was possible
that the pulled-tip emitters became partially clogged and altered the overall split. That is, the linear
velocity of the solvent was decreased by more than half.
To address the problem of altered flow rates, in the subsequent experiments that are
reported above (Figures 4-1 and 4-2), the emitter tip diameters were widened (from 25 to 100 μm)
to ensure a similar flow rates throughout the LC run. These efforts dropped the peak width
disparities from the previous factor of ∼2.5 to values of ∼1.10−1.20 obtained for the data
presented in Figures 4-1. Presently, it is not known whether the larger tip diameter decreases the
advantage that cVSSI exhibits compared with ESI. That said, the purpose of these experiments
is to demonstrate the current advantage in the 30−50 μL·min−1 flow range. Exhaustive studies to
determine optimal flow rates, voltages, vibration amplitude, and emitter tip diameter size are
beyond the scope of this study and will be conducted in the future. It should be noted that one
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way to avoid problems of changing flow rates is to eliminate the solvent splitter. This option is not
currently available for the instrumentation used in this study as the LC system does not provide a
reliable flow below ∼150 μL·min−1. That said, many commercial LC systems do provide stable
flow rates within the targeted range of this study

4.4. Conclusion
Proof-of-principle experiments have been conducted to determine the efficacy of field-enabled
cVSSI as an ionization source for microflow LC-MS experiments in both positive and negative ion
mode. In head-to-head comparisons with a commercial ESI source, field-enabled cVSSI is shown
to provide significant improvement in ionization efficiency in both positive and negative ion mode.
The effect is more pronounced for negative ion mode analyses where improvements of 4 ± 2- fold are obtained for metabolomics-type samples. In positive ion mode, the gains are more
modest. Here, compound ionization is improved by 4 ± 2-fold for metabolomics-samples. The
peak broadening associated with the negative ion mode analyses appears to be primarily
associated with a reduction in the split ratio occurring during the separations as the flow rates
were measured prior to the separate analyses. The problem is addressable with a LC system that
can provide lower flow rates or with a programmable splitter.
Taken together, the results presented here demonstrate that field-enabled cVSSI can provide
significant enhancements in ionization compared with state-of-the-art ESI for microflow LC-MS
separations. This advantage holds in both negative and positive ion mode. Such results are
remarkable considering that very little developmental work has been directed toward cVSSI
technology. A number of other factors should be investigated to further enhance ionization
efficiency beyond that capable by ESI. For example, limited observations suggest that ionization
efficiency scales as the emitter tip vibration amplitude in field free cVSSI. Additionally, the jagged
nature of the emitter tip also improves ionization. Therefore, many factors ranging from vibrating
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substrate material to emitter tip geometry and orientation will need to be investigated in the near
future to realize the full ionization enhancement that can be accessed with field-enabled cVSSI.
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5.1. Introduction
Found both on the cell surface and intracellularly, carbohydrates play numerous roles in
biological systems [1–3]. Carbohydrates are important biomolecules and they are involved in
many biological processes such as preservation of bimolecular structure, energy storage, protein
folding, immune response, intra- and intercellular recognition and signaling [1, 4–7]. Even simple
sugars such as glucose and fructose are involved in important metabolic pathways and, therefore,
the study of simple sugars as part of comparative metabolomics is important for the identification
of new biomarkers for early disease diagnosis and monitoring disease progression [8–12].
Disaccharides themselves are also important; they are often the products of enzymatic activity
and hence a detailed structural characterization is important for practical applications [1, 13, 14]
An understanding of the biopathways affected by changes in molecular concentrations as a
function of physiological state may play a crucial role for developing effective treatments for many
diseases [2, 15]
Structural characterization of carbohydrates is a challenge for several reasons. Currently
there are limitations in the availability of analytical tools for full characterization due to the
complexity of carbohydrate structures which arises due to the existence of numerous isomeric
forms [3, 16] . Isomerism in carbohydrates occurs in part because there are rings of different size
in which the compounds may exist. Additionally, the furanose and pyranose forms gives rise to
two possible anomeric configurations, α and β. In addition, carbohydrates are constructed from
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at least 20 different monosaccharides that may be linked at any position on the saccharide ring
giving rise to position and linkage isomers [6, 17–19].The diverse and complex functions of
carbohydrates in living cells may be related to the high density functional (predominantly hydroxyl)
groups present in these compounds [1]. These properties present challenges when conducting
comparative metabolomics studies and invite the development of innovative measurement
technologies and techniques [15]. Characterizing the conformational properties of disaccharides
in the gas-phase may represent a key step towards a better understanding of carbohydrate
structure as well as the flexibility and dynamics of more complex carbohydrates. In the context of
MD simulations disaccharides also represent important benchmark systems for validating
simulation methodologies [1, 20, 21].
Nuclear Magnetic resonance spectroscopy (NMR) is a powerful tool used for the structural
elucidation of biological compounds [22]. However, the technique suffers limitations in the
analysis of mixtures of isomers and also requires significant amounts of sample for structure
characterization [23–25]. Additionally, because of carbohydrate flexibility, NMR provides only the
data-averaged structure sampled from many possible conformations [13]. Immunoassays are
also a powerful tool that can be used for the analysis of carbohydrates, but these are limited for
complex structures and mixtures due to matrix effects [26]. Mass spectrometry (MS) has been
widely used for carbohydrate structural analysis [13, 27–29]. The complex isomeric mixtures
hinder structural analysis by MS and therefore, the addition of pre-separation techniques such as
capillary electrophoresis (CE) [30–32], gas chromatography (GC) [33, 34] and liquid
chromatography (LC) [35, 36] can aid structural elucidation. These techniques separate ions by
retention and migration times and facilitate the structural identification of the carbohydrates.
Despite their wide scale use, separation techniques have limitation in the characterization
of carbohydrate samples. CE is often not compatible with the commonly used electrospray
ionization (ESI) ionization source for highly polar species[14] ; GC-MS requires the derivatization
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of compounds of interest [37] ; LC often fails to distinguish isomers that have the same retention
times [25, 38, 39]. In some cases LC-MS can be combined with tandem mass spectrometry
techniques (LC-MS/MS) to provide better compound structural characterization. LC-MS/MS can
be one of the more sensitive techniques to identify differences in isomeric and isobaric species.
That said, in the case of coeluting compounds, it may be difficult to discern ion fragments
associated with one species from those of another [15, 40] In cases where fragmentation of
isomeric species is performed, the process often produces ions of the same mass, requiring
multistage tandem mass spectrometry (msn) for compound identification [14, 41]. Although msn
analysis for individual ions has been widely used for structural characterization, the method has
challenges when isomers having identical mass-to-charge (m/z) value exist in a sample mixture
[41, 42].
Ion mobility-mass spectrometry (IMS-MS) is a technique that involves a rapid gas-phase
separation of ions prior to their mass analysis [43]. The technique has been in use for more than
two decades and has been widely used for the analysis of complex biomolecules [44] . IM-MS
separates ions based on differences in their mobility through an inert buffer gas under the
influence of a constant electric field. Differences are characterized through arrival time or drift time
distributions (millisecond timescale) and are determined by ion size, shape, and charge [38, 43]
In recent years, IMS-MS has emerged as a powerful technique for the analysis of carbohydrates
because of its capability to separate isomeric species [42]. Although not entirely orthogonal, IMSMS can be envisioned as a two-dimensional separation scheme to obtain mass-mobility spectra.
In the context of isomer characterization, for a given m/z value, IMS-MS may provide multiple
features providing information on the presence of isomers [17, 25]. IMS-MS offers several
advantages compared with traditional measurement techniques contributing to an overall
enhancement in resolving power thereby improving its performance in the separation of
carbohydrates [39]. In addition the technique is highly sensitivity as it removes signals from low-

142

intensity ions from the interfering signals of higher-intensity species, thereby increasing the overall
peak measurement efficiency [15].
Clemmer and Liu (1997)

were the first to apply IM-MS for the characterization of

oligosaccharides using an injected-ion mobility instrument [45]. They demonstrated the ability to
use drift time (tD) distributions of the carbohydrates to distinguish between different isomeric forms
of parent and fragment ions having the same m/z values [45]. Dwivedi et al, have shown the
applications of IM-MS for the separation and detection of isomers of complex carbohydrates[46].
Since the time of these early studies, there have been many experiments of carbohydrate
characterization with ion mobility mass spectrometry [7, 47–49]. It has been demonstrated that
IMS-MS is capable of characterizing gas-phase conformers, chiral molecules and isomers even
without a prior knowledge of molecular structure as well as to provide ion dissociation spectra for
each [17].
Although IMS-MS is an enabling technique for the characterization of carbohydrate
compounds, it suffers from competitive ionization because of it is effectively a post ionization
measurement. Additionally, the overall separation capacity is limited because ion mobilities are
correlated to some degree with m/z values such that there may be an overlap between isomers
and isobars having similar drift times. This may cause incorrect identification of sample structures
due to inaccurate collisional cross section (CCS) calculations [15, 50]
The limitations in peak capacity afforded by the IMS-MS approach may be overcome to
some degree with the addition of another orthogonal measurement technique such as
hydrogen/deuterium exchange (HDX). Nikolaev et al. (2014) presented an investigation of HDX
of carbohydrate ions occurring in the electrospray ion source [13]. However, limitations arise from
an inability to distinguish gas-phase from solution-phase HDX. Gas-phase HDX combined with
MS has been demonstrated as a tool to determine protein structure and conformational changes
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[13, 47, 51, 52]. Recent studies have shown that the technique could also be applied to other
types of compounds [15, 53, 54] With this technique, ions travelling in the drift tube are encounter
a partial pressure of D2O molecules resulting in the incorporation of deuterium which is monitored
by a shift in the isotopologue envelope [9]. It has been claimed that the exchange rate of an ion’s
heteroatom hydrogen is dependent upon many factors such as its position, basicity and
involvement in hydrogen bonding[9]. For small-molecule analysis it has been shown that different
amino acids exhibit different deuterium uptake patterns [15, 41]. Overall, it has been determined
that the exchange of hydrogens for deuterium atoms with D2O reagent gas at labile sites (charge
sites and other heteroatoms) occurs via a relay mechanism [41, 55] and thus exchange sitecharge site proximity is a limiting factor.
In a previous study, the utility of IMS-HDX-MS for ‘omics’ mixtures analysis, the
distinguishing of isomeric and isobaric species [15] was demonstrated; even though there are
less hetero-atomic hydrogens in small molecules, unique isotopic distributions can be observed.
Additionally, a combination of IMS-HDX-MS and collision-induced dissociation (CID) can be used
as an analytical tool for mixture characterization [15]. In these experiments it was shown that the
D2O reagent could serve a as tuning parameter as compounds exhibit unique HDX reactivities at
different D2O partial pressure settings [15] due to differences in reaction kinetics. Additionally,
hydrogen accessibility scoring (HAS) and HDX kinetics modeling of candidate (in-silico) ion
structures generated using MD simulations were utilized to estimate the relative ion conformer
populations giving rise to specific HDX behavior
Recently studies have shown that examination and prediction of fine structures within a
biological compound class can be achieved with further computational strategies, such as MD
simulations [20, 56, 57]. Additionally, the structural information of biomolecular ions is also
obtainable through comparing results from molecular modeling with collision cross section (CCS)
values derived empirically from tD distributions for specific separation conditions [15, 58, 59]. CCS
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reveals structural information about the average size of gas ion conformers; theoretical CCS
values can be obtained by modeling the collision dynamics of computer-generated trial structures
for biomolecular ions [56, 60, 61]. The present study expands on previous work demonstrating
the utility of IMS-HDX-MS for ‘omics’ mixtures analysis [41]; this is accomplished with the
development of a method for distinguishing three disaccharide isomers with gas-phase HDX. The
three disaccharides, trehalose, sucrose and palatinose, have the same chemical formula and the
same number of hydroxyl (-OH) groups. Trehalose is known to have the ability to protect biological
structures, sucrose and palatinose are sources of energy for the cells [21]. Here the HDX
mechanism is considered with regard to any given hydrogen’s accessibility for exchange to relate
the experimental data to the structures of disaccharide ions.

5.1. Experimental
5.2.1. Chemicals and Solvents
Palatinose (≥ 99% Hydrate); sucrose ((≥ 98.0%) and trehalose ((≥ 98.0%) were obtained
from Sigma-Aldrich (St. Louis, MO, USA). Optima® LC/MS grade acetonitrile and LC/MS grade
water were purchased from Fischer Chemical (New Jersey, NJ, and USA). Deuterium Oxide (99.9
atom % D) and ammonium hydroxide were purchased from Sigma-Aldrich (St. Louis, MO, USA).
All standards and solvents were used without any further purification.

5.2.1. Sample Preparation
1mg/ml of each standard disaccharide solutions were prepared in a 1:1 water: acetonitrile
solution. 1% of ammonium hydroxide was added to aid compound ionization.

5.2.2. Ion Mobility Spectrometry-Mass Spectrometry (IMS-MS) Measurements.
Ion mobility experiments were conducted on a home-built, dual-gate IMS device coupled
to a Thermo LTQ Velos mass spectrometer (Thermo Fisher, San Jose, CA) which has been
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described in detail elsewhere (Figure 5-1) [62]. Briefly, samples were infused through a pulled-tip
capillary that is biased at ±2500 V relative to the desolvation region and ions were separated
under the influence of a constant electric field (10V/cm). The desolvation region consists of an ion
funnel trap where ions are periodically stored at a frequency of 50 Hz and released into the drift
tube [63, 64]. Measurements for ion mobilities were collected at a He buffer gas temperature of
300 K and a pressure of ~2.5 Torr for the trehalose, sucrose and palatinose ions. The application
of a ion gating at the back of the drift tube enabled the recording of tD-resolved mass spectra for
each disaccharide [41]. A step size of 0.2 ms was used to scan across the entire tD range. The
mass spectrum data was obtained with the X-caliber software suite (ThermoScientific). The mass
spectra were converted to text files using Notepad (Microsoft) and replotted in Excel (Microsoft)
for the creation of the isotopic distributions.

ESI
Source

F1/IA1/G1
F1/IA1/G1

He:D2O

LTQ Velos

Drift Tube

Desolvation
Region

baratron

ETD

octopole

F2/IA2/G2 quadrupole

LIT

Figure 5-1.Schematic representation of the instrument used in the current studies. The abbreviations F,
G, and IA represent ion funnel, ion gate, and ion activation regions, respectively.

In-house software was used to assemble a 3-column array file (text) containing tD and m/z
values with associated ion intensities for the calculation of CCS values [41]. The sum of the tD,
and time required to travel through the interphase regions is the total time required for an ion to
transverse through the instrument [65]. Experimental collision-cross sections (Ω) were calculated
using the following equation [41] ;
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In Equation 1, P is the pressure of the buffer gas, N is the number density of the neutral buffer
gas at STP. L is the length of the drift tube, ze is the charge of the ion, E is the electric field
strength, T is the temperature of the buffer gas, Kb is Boltzmann’s constant and mi and mb are the
masses of the ion and the buffer gas, respectively.
For the HDX measurements, partial pressures of ~0.02 Torr of D2O were added to the drift
tube containing the He buffer gas at ~2.5 Torr and 300 K using a separate leak valve.
Measurements for sucrose and trehalose were recorded at tD values of 6 ms and palatinose at
6.2 ms. For the three disaccharide ion conformers, the number of incorporated deuteriums was
determined by subtracting the precursor ion average mass before and after exposure to D2O. For
reproducibility determinations, measurements were taken in triplicate for each sugar.

5.2.4 Molecular Dynamics (MD) Simulations
All MD simulations were carried out using NAMD version 2.11 and VMD version 1.9.1,
with the CHARMM carbohydrate force field. The aim was to produce in-silico candidate ion
structures of the gas-phase conformations of the electrosprayed ions of sucrose, trehalose and
palatinose. The initial PDB files for each disaccharide were obtained from the Pubchem.. Since
negative mode electrospray ionization was used to generate singly charged ions in IMS-MS,
different configurations of each disaccharide were created by deprotonation of the hydrogen atom
from the hydroxyl (-OH) group on different carbon atoms on the two residues. The charges for all
monomers in the topology file are neutral. To be able to create an overall formal charge of -1 on
the charge site, the force field parameter of the ionized alcohol was utilized [1]
Trehalose (α-D-glucopyranosyl-(1→1)-α-D-glucopyranoside) (Table 5-1) is a disaccharide
formed by a 1, 1-glycosidic bond between two α-D-glucose units. Deprotonation was performed
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on eight different sites on the two monosacharrides units and have been labelled (T1GHO2,
TGHO3, T1GHO4, T1GHO6) and (T2GHO2, T2GHO3, T2GHO4, T2GHO6). T1GHO2 refers to
deprotonation of a hydroxyl group on the first glucose (1G) residue of trehalose (T) attached to
oxygen atom number two (HO2). In a similar manner T2GHO3 refers to the deprotonation of the
hydroxyl group attached to the second glucose residue (2G) residue of trehalose (T) attached to
oxygen atom number three (H3).
In

sucrose

(O-α-D-glucopyranosyl-(1→2)-β-D-fructofuranoside)

(Table

5-1)

the

components of α-D-glucose and β-D-fructose are linked by a glyosidic linkage between C1 on the
glucosyl subunit and C2 on the fructosyl unit. The glyosidic bond is formed between the reducing
ends of both glucose and fructose. Deprotonation was exacted on eight different sites, four on the
α-D-glucose moiety and the other four on the β-D-fructose moiety. The deprotonation sites have
been labelled (SGHO2, SGHO3, SGHO4, SGHO6) α-D-glucose and (SFHO1, SFHO3, SFHO4,
SFHO6) β-D-fructose.
Palatinose (6-O- α-glucopyranosyl-D-fructose) (Table 5-1) is formed between Dfructofuranose attached to an alpha-D-glucopyranosyl unit at position 6 via a glycosidic linkage.
Deprotonation was performed on eight different sites (PGHO2, PGHO3, PGHO4, and PGHO6)
α-D-glucose and (PFHO1, PFHO3, PFHO4, PFHO6) α -D-fructose. The nomenclature is similar
to that used for trehalose and sucrose. PGHO2 refers to deprotonation of a hydroxyl group on the
glucose (G) residue of palatinose (P) attached to oxygen atom number two (HO2). In a similar
manner PFHO3 refers to the deprotonation of the hydroxyl group attached to the fructose (F)
residue of palatinose (P) attached to oxygen atom number three (HO3).
MD simulations were conducted for all the deprotonated structures for palatinose and
sucrose, whereas only four were performed for trehalose( the other four have exactly the same
structures). Each MD simulation was performed at 300 K for 100 ns using a 1 fs time step. For
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the force-field parameters, the (par_carb.prm ) file was used [72]. The DCD frequency, restart
frequency and output pressure were set at 2000. The switch distance for the sugars was set at
18.0 Å , cutoffs at 20 and the pair list distance at 22. All bond lengths involving hydrogen atoms
were restricted with the SHAKE algorithm and the constant temperature and pressure by the
Langevin coupling algorithm [21].

5.2.5 HDX Accessibility Modeling
50,000 structures were obtained from the MD simulations and the XYZ coordinates for a
1000 structures were selected with a 50-stride spacing algorithm in the VMD graphical interface.
CCS values for buffer gas He interactions were computed for all in-silico structures using the
trajectory method in the MOBCAL software [66, 67]. Candidate structures within 2% of the
experimental CCS values were extracted for HDX accessibility modeling. In-silico structures with
matching experimental values of 112 A2 for trehalose were selected using a code, run in the
python software. An in-house script determined the distance of each heteroatomic hydrogen from
the charge site for each ion structure. Using these, the percentage of each hydrogen type at
different threshold distances from the charge site were determined using all structures having
matching CCS values. This process of HDX accessibility modeling was repeated for the selected
structures having matching CCS values for sucrose and palatinose.
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 Deprotonation of the charge site
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Figure 5-2. Summary of molecular dynamics (MD) simulations work. The dark blue rectangles represent
the software used for each step of the accessibility modeling. The light blue rectangles show the processes
accomplished by each software application.
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Table 5-1. Disaccharides molecular structure and CCS values

eMolecular

structure drawn using Chem Drawer software suite
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5.3. Results and Discussions
5.3.1.Experimental Isotopic Distributions.
Investigations of carbohydrates isomers by IMS-CID-IMS-MS have reported CCS values
for [M + Li] + trehalose, sucrose and palatinose ions (m/z 349) of 105.1 Å2, 104.5 Å2 and 106.4 Å2,
respectively [65]. In another study the CCS values for the lithium adducts of sucrose and trehalose
were similar (Ω = 107.1 ± 0.3 Å2 for [sucrose + Li] + versus Ω = 107.9 ± 0.3 Å2 for [trehalose + Li]+)
[7]. As the size of the metal cation was increased, the CCS of trehalose adducts exhibited much
greater sensitivity to the cation size compared to the sucrose cationized species. The reported
values were Ω = 108.9 ± 0.3 Å2 for [sucrose + Na]+ versus Ω = 110.6 ± 0.4 Å2 for [trehalose + Na]+
[7]. From these studies, the data demonstrated that the conformations of cationized carbohydrate
depends significantly upon both the carbohydrate structure and the ionic radius of the bound
cation.
Here the CCS values of [M+Na]+ trehalose, sucrose and palatinose ions were determined
to be 113.6 Å2, 116.1 Å2 and 118.8 Å2, respectively Notably, the values obtained are slightly higher
than those obtained previously. This could be attributed to the differences in instrumentation
employed. It is possible that ions could be slightly delayed in the first ion funnel region due to the
effects of the RF field. Although, admittedly, all other CCS values obtained from this instrument
have been within 2% of experimental values obtained by others. The experimental CCS values
for the disaccharides [M -H]- trehalose, sucrose and palatinose ions were found to be 112 A2,
112.4 A2 and 114.0 A2 respectively (Table 5- 1). Trehalose is the most compact ion having a CCS
value centered at 112 A2 and palatinose is the most elongated ion with a CCS value centered at
114 A2. The CCS values alone from the IMS-MS cannot distinguish the isomers as they all exhibit
similar values.
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HDX is used as an orthogonal analytical technique to IM-MS and presents a potential
method for the distinguishing of isomeric carbohydrate ion structures as they contain many
hydroxyl groups with labile protons. The ions of trehalose, sucrose and palatinose have the same
molecular weights and numbers of hydroxyl groups but different structures (Table 5-1). The
amount of deuterium incorporated into the ions was determined by subtracting the average m/z
value of the precursor ions from the average value of the same ion after undergoing HDX. In
negative ion mode, the disaccharide [M-H]

-

ions having a m/z value of 341 comprise the

monoisotopic dataset feature. When D2O is introduced into the drift tube at a partial pressure of
~0.02 Torr, the [M-H]- ions of trehalose, sucrose and palatinose incorporate ~1, ~2 and ~3
deuteriums on average, respectively. Thus it appears that this approach may provide an ability to
distinguish isomeric species.
The isotopic distribution for the three disaccharide ion datasets upon exposure to D2O are
shown in Figure 5-4. Trehalose shows the least amount of deuterium uptake (Figure 5-4a),
compared with the other disacharides. The distribution is skewed to the left, with D1 (m/z 342)
exhibiting the greatest intensity. The other isotopologues in order of decreasing intensity are D2,
D0, D3, D4, D5, D6 and D7. Palatinose (Figure 5-4c) shows the most HDX reactivity (~3
exchanges on average). The isotopic distribution is skewed to the right compared to the other two
disaccharide samples. The major isotopologue is the D3 feature; this is followed by the D4, D5,
D2, D6, D1, D0 and D7 isotopologues in order of decreasing intensities. Sucrose exhibits a m/z
shift where D2 is the major isotopologues (Figure 5-4b). The other isotopologues are D3, D1, D4,
D5, D0, D6 and D7 in order of decreasing intensities.
Trehalose has been shown to occur naturally with a lowest-energy conformation of α-Dglucopyranosyl-(1, 1)-α-glucopyranoside among the possible isomers (α,α-; α,β-; β,β-)[21].
Trehalose is the most stable natural disaccharide from a thermodynamic and kinetic perspective
with a glyosidic bond energy (-4.2 kJ/mole) which is lower than that of sucrose (+113 kJ/mole)
153

[21]. This may explain why trehalose exchanges fewer hydrogens (only ~1 on average) as
compared to sucrose and palatinose. HDX occurs via the relay mechanism,[68, 69] which is
dependent upon the surface accessibility of the charged sites as well as the distance between
the charge site and any exchange site [55]. A long-lived reaction intermediate must be formed
bridging the charge site and a less basic(positive ions)/acidic(negative ions) site [55,70].
The amount of incorporated deuterium is dependent upon the rate of HDX of the ions
which in turn is dependent upon the ion structure and the atomic composition [15]. As the unique
HDX behavior distinguishes the two disaccharides trehalose and sucrose which have similar CCS
values, it is instructive to consider possible explanations. That trehalose exhibits lowered reactivity
suggests that fewer hydrogens are within an “accessible” distance to the charge site. This hinders
the formation of the reaction intermediate leading to less HDX exchange. Palatinose has more
deuterium incoporation suggesting increased charge site accessibility, on average, by the
exchange site hydrogens [71]. MD simulations were conducted to understand the specific HDX
behavior and to better correlate structures to the deuterium uptake determined experimentally.

5.3.2. MD Simulations for HDX Accessibility Modeling.
In-vacuo MD simulations (in-vacuo) were used to generate candidate ion structures (see
Experimental section). Figure 5-5 shows CCS values for ion structures having different charge
sites plotted against the potential energies for the computer-generated candidate structures. The
difference in number of candidate structures is largely dependent upon the type and rotation of
the linkage between the two-monomer sugars. For other charge site configurations there are more
hydrogens accessible to the sites, more ion structures are necessary to be examined.
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Figure 5-3. Isotopic distributions of the [M-H]- ions for trehalose, sucrose, palatinose obtained upon using
~0.02 Torr of D2O. 1 mg/ml standard solutions in water: acetonitrile (1:1) solution. Ammonium hydroxide
(1%) was added to aid compound ionization. Figure 4a shows the disaccharide trehalose major
isotopologue (D1), Figure 4b shows major isotopologue (D2) for sucrose and Figure 4c shows that (D3) for
palatinose.
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The deprotonation site for a given disaccharide is not known; therefore, deprotonation was
performed for all the possible sites (T1GHO2, T1GHO3, T1GHO4, T1GHO6, T2GHO2, T2GHO3,
T2GHO4, T2GHO6). A total of 50,000 structures were generated from each MD simulation of
each of these charge site configurations. A thousand structures were selected randomly (see
Experimental section) for CCS calculations from each MD trajectory. Candidate structures within
2% of the experimental CCS values (110-114) A2 were then selected for hydrogen-charge site
distance calculations. A considerable number of in-silico candidate structures matching
experimental CCS values were obtained including: 105, 655, 694 and 112 for T1GHO2, T1GHO3,
T1GHO4 and TGHO6 charge site configurations, respectively. Figure 5-5a shows the CCS values
plotted against the potential energy for structures from the T1GHO4 charge configuration MD
trajectory.
The deprotonation sites for sucrose were SGHO2, SGHO3, SGHO4, SGHO6, SFHO1,
SFHO3, SFHO4, and SFHO6 (see Experimental section). A total of 50,000 structures were
obtained and the XYZ coordinates for 1000 structures (selected at random) were analyzed with
MOBCAL. Candidate structures within 2% of the CCS values for sucrose (110-114) A2 were
selected for hydrogen-charge site distance calculations including: SGHO2, SGHO3, SGHO4
SGHO6, SFHO1, SFHO3 and SFHO4 which produced 133, 381, 527, 431, 176, 371 and 253
matching structures, respectively. There were no candidate structures found for the SFHO6
charge site configuration. Figure 5-5b shows the collision cross section plotted against potential
energy for the SFHO4 charge site configuration.
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Figure 5-4. CCS values versus potential energy for a) trehalose, T1GHO4 b) sucrose SFHO4 and c)
palatinose PFHO4 MD trajectories.

The structures generated for palatinose contained the charge site configurations PFHO2,
PFHO3, PFHO4, PGHO2 PGHO3, PGHO4, and PGHO6. The few in-silico candidate structures
having matching CCS values were 184, 30, 31, and 92 in number for PFHO4, PGHO2, PGHO3
and PGHO4 respectively. An even fewer structures were obtained for PFHO1, PFHO2 PFHO3,
PGHO6, 1, 4, 2 and none respectively. Figure 5-5c shows the collision cross section plotted
against potential energy for the PFHO4 charge site configuration MD trajectory. Figure 5- 6 shows
the some of the ion structures of trehalose (T1GHO4, T2GHO2), sucrose (SFHO1, SFHO4) and
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palatinose (PFHO4, PGHO4) selected for calculations of distances between charge sites and
exchange sites.

5.3.3. Exchange-site/Charge-site Distance Modeling
It has long been established that gas-phase HDX for which the lower-basicity solvent of
D2O is used takes place via the ‘relay’ mechanism [55][69]. This reaction involves both the charge
site and neighboring basic or acidic sites for deuterium shuttling. This implies that the surface
accessibility of the charge sites and the acidic (in this case) sites and the distances between them
play an important role in HDX efficiency. This is because the formation of the long-lived reaction
intermediate is necessary for the HDX reaction to proceed. The data from the MD simulations are
used to investigate the distances of the heteroatom hydrogens to the charge sites. In that regard,
the MD simulations are also performed to better understand the relative experimental deuterium
uptake values
Accessibility profiles for individual exchange sites were calculated for all ion structures
having matching CCS values within individual MD trajectories. Here the percentage of hydrogens
residing at single sites for all structures is shown as a function of the distance to the charge site.
Figure 5-7 shows a correlation between the “density” of charge sites and exchange sites
suggesting a possible governing factor for HDX. Figure 5-7a and 5-7b show the sigmoidal curves
for distance versus accessibility for trehalose T2GHO3 and T2GHO4 MD trajectories,
respectively. These trajectories contain the most candidate structures within 2% of the collision
cross section (110-114 A2) with respective values of 655 and 694.
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Figure 5-5. Candidate structures of disaccharide ions having matching CCS values. MD simulation
trajectories for these ions have been used to assess the effect of charge site and exchange sites density
on the overall level of HDX for the different disaccharide ions.
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The graphs show that most of the hydrogen accessibility profiles are shifted to the right
and only two are shifted to the left within a distance of 1 Å. This would suggest that for these
deprotonation sites, fewer hydrogens may be available for HDX; notably, this could explain why
trehalose incorporates the least amount of deuterium experimentally compared with the other
disaccharides. The greatest hydrogen accessibility distance is between 4-7 Å for T2GHO3 (Figure
5-7a) and between 4-8 Å for T2GHO4 (Figure 5-7b). In this argument, the further the hydrogens
are located from the charge site, the less likely an intermediate can be formed for exchange to
take place via the relay mechanism.
Figure 5-7e and 5-7f show the accessibility curves representing HDX exchange for
palatinose via the PGHO2 and PFHO4 charge site configurations, respectively. Unlike Figure 57a and 5- 7b for trehalose, more curves are shifted to the left, suggesting that more hydrogens
are available for exchange. For both Figure 7e and 7f, 100% of three hydrogen types are within
1 Å distance from the charge site. From the experimental data, palatinose (5-4c) is shown to have
the most deuterium uptake (majority D3 dataset feature). These data for HDX efficiency modeling
relate well with the exchange that is observed experimentally. The remaining hydrogens are
generally within 4-5 Å for PGHO2 (figure 7e) and 2-7 Å for PGHO4 (Figure 5-7f). These are shorter
distances compared to trehalose which showed 4-7Å for T2GHO3 (Figure 5-7a) and 4-8Å for
T2GHO4 (Figure 5-7b).
Sucrose has a similar collisional cross section to that of trehalose but the isotopic
distributions are different (Figure 5-4a and 5-4b). The sigmoidal accessibility curves are similar;
2 hydrogens are generally within 2 Å distance of the charge site (Figure 5-7c and 5-7d) for SGHO3
and SFHO4 charge site configurations, respectively. However, more hydrogen accessibility
curves are shifted to the left (Figure 7c and 7d) compared with trehalose (Figure 5-7a and 5-7b).
The calculations for the SGHO3 charge site configuration places the other 5 hydrogens as
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generally accessible within 3-7 Å while the SFHO4 configuration does so for the remaining
hydrogens at distances of 3-6 Å.
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Figure 5- 6. Accessibility profiles for individual exchange sites. Here the percentage of exchangeable sites
across all ion structures having matching CCS value is shown as a function of their distance to the charge
site for (a) T2GHO3 (b) T2GHO4(c) SGHO3 (d) SFHO4 (e) PGHO2 (f) PFHO4 ions. The Figure shows a
correlation between the density of charge sites and exchange sites suggesting a governing factor for HDX.
Panels a and b show results trehalose, panels c and d show results for sucrose, and panels e and f show
results for palatinose ions.
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5.4. Conclusion
IMS-HDX-MS has been used with MD simulations to gain structural insight into small
carbohydrate ions. The density of charge site and exchange sites appears to play a significant
role in the rate of HDX of the individual ions resulting in the distinctive HDX patterns. This work
further confirms that, despite the limited number of hydrogen atoms in small molecules, unique
isotopic distributions can be produced and these may distinguish simple disaccharide isomers.
The results presented here also demonstrate the combination of MD simulation data to provide
possible explanations for the observed experimental results. The continued exploration of HDX
reactivities for different compounds with the assistance of MD simulations will help to better
understand phenomena that affect the overall exchange levels that are observed. Thus such
studies could have significant implications for the development of tools to aid compound
identification in experiments encountered in metabolomics investigations. Additionally, such
studies could further reveal the utility of gas-phase HDX combined with IM-MS to provide
information about the structures of intractable species such as protein complexes and intrinsically
disordered proteins.
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6. Future Directions- Application of Developed Methods to Improve
Characterization for Small Molecules in Real World Samples

6.1. Introduction

The work presented in this dissertation showcases a number of proof-of-principle
experiments. Additional experiments can be performed to fully understand the utility of these
methods with regard to characterization of real-world samples as well as their applications in
biomarker discovery. The future directions section outlines a number of experiments that could
be conducted for these purposes.

6.2 Construction of a Library with HDX Patterns and Prediction of HDX Patterns

The HDX behavior of metabolite ions depends on the atomic composition and structure of
the ions (i.e. the number and type of heteroatomic hydrogens and their accessibility). Throughout
the work that has been presented in this thesis, it has been shown that isotopic distributions
resulting from the HDX reactions can also serve as a unique identifier for compounds. The results
presented in Chapter Two are very encouraging as the isotopic distribution patterns and
deuterium uptake have been found to be highly reproducible. With an optimized setup, this
approach can be utilized to create a compound database. Admittedly, the construction of a
database of sufficient size with HDX information is a Herculean effort. That said, such a database
could be utilized in a manner that is similar to El-MS spectral matching. In this future direction
project, a database of isotopic distribution patterns together with the deuterium uptake for
metabolites with different moieties or functional groups would be constructed. Although initially
such a database would likely consist of new buildout as an independent database, it can be
envisioned that, with widescale adoption of pattern matching, the HDX data could be could simply
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be added to an already existing metabolite database (HMDB [1], KEGG [2], ChemSpider [3] etc.)
.
One question that arises with a database strategy whether or not the usage of the cVSSI
setup would be relevant across different mass spectrometer instrument platforms. From the
experiments conducted in these studies, it has been shown that solution-phase HDX depends on
a number of factors. This includes capillary tip sizes, distances of the devices from the inlet of the
mass spectrometer, different diameters of the inlet capillary (i.e., different mass spectrometers)
as well as the environmental conditions. This may introduce a number of challenges to set
standard conditions for all solution-phase HDX reactivity studies for the dual cVSSI platform. That
said, an improvement in the identification of metabolite compounds of even two-fold would be
groundbreaking and greater compound resolution is a stated goal of the National Institutes of
Health [4].
Another important aspect of the data presented from experiments described in Chapter
Two is the ability to use computational tools for the prediction of isotopic distributions of various
compounds. To date, little work has been performed with regard to the development of prediction
tools for HDX behavior of metabolites. The ability to predict isotopic patterns upon HDX would
significantly enhance compound identification in complex mixtures analyses especially
considering that many species are not present in any database (e.g., all chemicals in the
exposome) [5]. The accuracy in the prediction models presented in Chapter Two was limited by
the relatively small sample size used for the training set; only 18 compounds were studied. With
a larger sample cohort, the accuracy of the models may be improved significantly. The approach
could be particularly useful for some metabolites that are not commercially available for
experimental measurements as well as emerging compounds especially new drugs or new
metabolites that will not be present in any database.
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6.3. Application of the Dual-capillary HDX Platform for Antibody Analysis

Professor Brandon Ruotolo’s research group has extensively studied collision-induced
unfolding (CIU) for proteins and protein complexes using IMS-MS technique [6]. Native CIU
tracks the stability and unfolding of gas-phase proteins ions through stepwise heating and this
provides information on gas-phase unfolding mechanisms. They have also demonstrated a
thorough characterization of antibody-drug conjugates (ADCs) through a combination of
techniques such as LC-MS, native IMS-MS AND CIU analysis [7]. Additionally, HDX mass
spectrometry has been applied for the analysis of biotherapeutics to characterize high
concentrations of monoclonal antibodies [7, 8]. The work presented in Chapter Three showing
the ability to distinguish isomeric glycans with the use of in-droplet HDX on very short timescales
has the potential to provide additional information in the characterization of proteins such as
antibodies.
A future application of the dual cVSSI for HDX-MS may be the characterization of antibody
glycans; the platform may find utility in characterizing the glycoforms of biotherpeutics from
different batches as well as biosimilars. The basic idea is that the glycans from the antibody
sample could be enzymatically removed, cleaned, and then subjected to LC-cVSSI-HDX-MS
analysis. The basic separation protocol for the glycan mixture analysis could involve reversedphase liquid chromatography using methods developed previously [9, 10]. As envisioned, eluting
glycans would be subjected to on/off cycles of D2O droplet mixing as well as MS and MS/MS
analysis. In this manner, precursor ion, ion exchanged, ion exchanged MS/MS, and MS/MS data
could be obtained through cycling the D2O reagent on and off as well as the mass spectrometer
functions for ion fragmentation. The information content from a single, high-throughput analysis
would be unparalleled. It would include precursor ion exact mass, isotopic distributions of the
exchanged ions, fragment ions from the precursor ion, isotopic distributions of the fragment ions
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from the exchanged ions, and chromatographic retention time. This would provide a glycan map
of each antibody sample against which comparisons could be made (batch to batch analyses or
biosimilars versus biotherapeutics). Such comparisons may be as distinguishing (or more) as
CIU studies have been.

6.4. Development of a Multiarray Platform for Microflow LC Separations

LC-MS analysis has been widely used for metabolomics studies. However, despite
decades of method developments, researchers still struggle with mixture complexity. One major
limitation is associated with the inability to efficiently ionize many metabolites in negative ion
mode. Another limitation is the inability to adequately identify and quantify low-signal species,
which often, are masked by the higher-abundant species in a mixture. The results presented in
Chapter Four of this dissertation provides a step a towards mitigating these limitations. These
experiments conducted with cVSSI as an ionization source for microflow LC-MS separations
provided encouraging results. Significant improvements in the ionization efficiency compared with
state-of-the-art ESI for microflow LC-MS separations for both positive and negative ion mode
analysis were demonstrated.
The next step along the path towards improving LC-MS platforms for these experiments
would be to combine the dual cVSSI-HDX-MS platform (Chapter Three) with the robust LC-cVSSIMS capabilities (Chapter Four) in the analysis of a real-world metabolomics sample. Polar and
non-polar compound extractions could be performed on pooled plasma samples or animal tissue.
With optimization of the different parameters including applied voltages, separation peak widths,
cVSSI reagent cycle frequencies, etc. the HDX analysis could be incorporated into a traditional
metabolomics workflow in a very efficient manner.
The design of the cVSSI platform enables post-separation column manipulation of the
solvent before the ions can be detected in the mass spectrometer. This has the potential to allow
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further improvements in ionization capabilities as well as in the identification of those less
abundant species from a metabolomics mixture. The setup presented in Chapter Four could be
easily modified and used as a platform for performing periodic in-droplet HDX reactions on the
flowing from the LC just before the ions are created for mass spectrometry analysis. This addition
of another orthogonal measurement could greatly enhance the identification of compounds by not
only introducing new assignments but also by eliminating false positive identifications in
metabolomics analysis.
Several studies have demonstrated that the ionization of some acidic compounds can
actually be enhanced in positive ion mode by employing metal cations to serve as the charge
carrier. Another modificaiton that could be made to this platform would involve creating a
multiarray cVSSI platform. For example, a tri-component platform could allow the use of in-droplet
reactions with HDX and metal ion adduction to enhance ionization and identification capabilities.
The advantage of using this setup is that the vibration process could be turned on and off and this
allows solvent mixing to only be performed when required. With such a setup, both protonated
and metal adduct species can observed; that is, both basic and acidic species can be observed
in a single experimental run. Additionally, the in-droplet HDX can be performed on both species
as well.
One positive outcome of the multiarray approach would be creating the ability to conduct
all-inclusive experiments for metabolomics analysis on a single reversed-phase (C18) LC column.
Being able to see both acidic and basic species in a single reversed-phase LC run would double
the throughput. Additionally, the cVSSI approach allows enhanced ionization capabilities for both
polar and non-polar metabolites on a single separation platform. For current metabolomics
analysis, many researches conduct metabolomics experiments on two separate columns, the
reversed-phase and hydrophobic liquid interaction chromatography (HILIC). to identify both polar
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and non-polar metabolites. Thus the new platform has the potential to double the throughput again
resulting in an overall 4-fold improvement in throughput.

6.5 Application of Fragmentation Techniques to Enhance Distinction of
Disacharides Isomers with Gas-phase HDX.
Tandem MS/MS techniques such as collision-induced dissociation (CID) have been
included in HDX-MS workflows [11, 12]. It has been demonstrated previously that by observing
fragmentation patterns for ions that have undergone HDX, valuable information about locations
of deuterium incorporation and hydrogen/deuterium (H/D) scrambling can be obtained [13, 14].
Although CID can help to provide structural information about select precursors ions [15]. The H/D
scrambling can result in the loss of valuable structural information such as the location of the
charge [14]. Thus, an understanding about functional groups and their relative access to the
charge site and to the basic site or original incorporation could not be obtained. CID is also limited
in the low mass range of the collected spectra which is typically a third of the mass of the precursor
ion [16]. Electron transfer dissociation (ETD) [17] and electron capture dissociation are (ECD)
[18, 19] are non-ergodic fragmentation techniques that have also been implemented and they
are generally not subject to H/D scrambling [20].
Charge transfer dissociation-mass spectrometry (CTD-MS) is a powerful new ion
fragmentation technique that has been developed by Professor Jackson’s group [21–24]. CTD is
a radical-driven fragmentation technique [22]. The fragmentation technique has been largely
implemented for the analysis of biomolecules such as peptides [22], lipids [25] and
oligosacharides [26]. For the latter species, CTD utilizes high-energy activation and therefore it
has demonstrated some appealing capabilities such as the production of prized cross-ring
cleavages [23]. This was particularly useful in the differentiation of isomers β-1,4- and β-1,3linkage isomers in native oligosaccharides [26]. Here it is proposeed the cVSSI-HDX-MS (Chapter
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Two and Three) and IMS-HDX-MS (Chapter Five) experiments be coupled with CTD
fragmentation capabilities. The valuable fragmentation process afforded by CTD could answer a
number of important questions raised in the studies described in these chapters. For example, in
Chapter Five, MD simulations suggested that ions having different deprotonation sites could
account for the isotopic patterns upon HDX. That is, the density of the charge sites and exchange
sites play a significant role in the resulting distinctive HDX patterns. However, the work is not
conclusive and merely provides a theory (most likely location of charge sites) to test. As CTD
provides unique fragmentation patterns including many cross-ring cleavages, it could be
invaluable in determining the locations of charge sites as well as the locations of deuterium
incorporation for both solution- and gas-phase HDX by carbohydrates. This information can be
very useful as it can enable us to better understand the structures of these carbohydrates in
solution as well as the carbohydrate ions.
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